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ROLE OF HOMOTROPIC ASSOCIATION OF LUTEININZING HORMONE 
RECEPTORS IN HORMONE MEDIATED SIGNAL TRANSDUCTION 
 
G protein-coupled receptors (GPCR) are plasma membrane receptors involved in 
signal transduction and are an important target for drug discovery. Luteinizing hormone 
receptors (LHR) are GPCRs found on the reproductive organs of both males and females 
and promote spermatogenesis and ovulation. Understanding how these protein receptors 
function on the plasma membrane will lead to better understanding of the mammalian 
reproduction system and other GPCR systems. Studies in the past suggested that these 
receptors oligomerize after hormone binding, but recent studies performed with LHRs 
suggest that these receptors maybe constitutively oligomerized in the endoplasmic 
reticulum and on the plasma membrane. However, these experiments were performed on 
receptors expressed by transient transfection and using bioluminescence resonance 
energy transfer (BRET). These methods have potential weaknesses. Transient 
transfections typically yield a fraction of cells with very high receptor expression and 
BRET measurements are strongly weighted towards those cells. Hence, this overall 
approach may have yielded misleading results. Fluorescence energy transfer (FRET) is a 
similar technique to BRET but has advantages such as allowing imaging examination of 
single cells. Using FRET, LHR oligomerization was evaluated on cells treated with 
ii 
 
human chorionic gonadotropin (hCG) or deglycosylated-hCG, hormones which activate 
and inhibit the receptor function, respectively. FRET measurements demonstrated that, 
on the surfaces of transiently transfected cells, LHRs exhibit substantial intermolecular 
FRET which is very slightly increased by hCG treatment and very slightly reduced by 
exposure to DG-hCG. Closer examination of these data showed that all observed FRET 
depended linearly on receptor expression and approach zero at low expression levels. 
This suggests that FRET between LHR on these transiently-transfected cells may arise 
from inter-molecular proximity induced non-specifically by high receptor surface 
concentrations. To evaluate the receptor density on cells flow cytometry was used. Flow 
cytometry revealed that transiently-transfected LHRs are expressed over a broad range of 
surface densities, including very high expression levels. Using a mathematical model, the 
FRET efficiencies expected for various receptor surface densities were calculated. These 
calculations suggest that expression levels observed cytometrically could cause 
substantial amounts of FRET from molecular crowding and, particularly if the receptors 
are additionally concentrated in lipid rafts, most of the observed FRET signal could be 
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Biological role of the luteinizing hormone receptor 
 
Healthy reproductive function relies on functional luteinizing hormone receptors. 
In females, the receptors are located on the ovary in luteal, granulosa and theca cells. On 
luteal cells, signaling by LHR promotes ovulation, corpus luteum (CL) formation, and 
maintains progesterone levels. On granulosa and theca cells, LHR promotes steroid 
production and follicle maturation for ovulation [1]. In males, LHR is located in the testis 
on Leydig cells and promotes sperm maturation and steroid production [2].  
 
In granulosa cells of the female, LHR regulates follicular development and 
triggers ovulation. Luteinizing hormone (LH) is released cyclically due to rising estrogen 
in the blood stream. As LH levels rise, the granulosa cells develop and transform to luteal 
cells to form the CL [2, 3]. This rise in estrogen creates a LH surge before ovulation, 
promoting the rupture of the ovulatory follicle, releasing an egg. The follicle forms a 
structure called the CL which produces progesterone, causing the uterus lining to thicken 
to receive a potential fetus. The CL is Latin for yellow body because a yellow-colored 
tissue fills the ruptured follicular cavity [2, 3]. If pregnancy occurs, human chorionic 
gonadotropin (hCG) is synthesized in the placenta by syncytiotrophoblastic cells [4] and 
helps prolong the lifetime of the CL. If no pregnancy occurs, progesterone is no longer 




Structures of luteinizing hormone receptor and cognate hormones 
 
 LHR binds the two hormones hCG and LH. LHR is a seven transmembrane (TM) 
domain receptor (Figure 1) and is called a “G protein-coupled receptor” (GPCR) because 
it activates G proteins for cell signaling. There are over 1000 GPCRs [5, 6], making this 
the largest class of membrane receptors. GPCRs are known for having similar structures. 
These receptors all have seven α-helical TM domains connected by three extracellular 
loops and three intracellular loops. The α-helical segments are each comprised of 25-35 
amino acids [7]. 
 
The LHR is a 669 amino acid single polypeptide chain [8] divided into three 
domains. The extracellular domain is a glycosylated N-terminal section with 340 amino 
acids responsible for ligand binding [9]. The transmembrane domain spans the 
phospholipid bilayer with each of the seven segments connected by three extracellular 
loops and three intracellular loops. The intracellular domain is the C-terminal 
cytoplasmic tail domain with 70 amino acids which aids in signal transduction of the 
receptor [10]. The rat LHR (rLHR) and the human LHR (hLHR) are both about 80,000 
Daltons (Da) [9] with amino acid sequence homology of 88% for the extracellular 
domain, 92 % for the TM domain and 69% for the intracellular domain [11]. 
 
Figure 2a-b is of human chorionic gonadotropin (hCG), a 74,000 Da glycoprotein 
hormone consisting of an α-subunit and β-subunit, 92 and 145 amino acids, respectively, 











Figure 1: Amino acid sequence of LHR. LHR consists of three domains. The 
extracellular domain is a glycosylated N-terminal domain with responsible for ligand 
binding. The transmembrane domain spans across the phospholipid bilayer with each of 
the seven segments connected by three extracellular loops and three intracellular loops 
and the intracellular domain is the last domain which is a C-terminal cytoplasmic tail 











Figure 2: Structure of hCG showing (a) the α-subunit and β-subunit held together by 
noncovalent interactions. The wrapping of the β-subunit around the α-subunit creates a 
distinctive “seat-belt” arrangement. From Hendrickson et al. [12].  (b) The hCG structure 





the α-subunit creates a distinctive “seat-belt” arrangement [14] which is essential for 
holding the subunits together. There are five disulfide bridges in the α-subunit and six in 
the β-subunit. While both subunits contain two N-linked carbohydrate sites, only the β-
subunit contains four O-linked carbohydrate sites [12, 13]. This is the only glycoprotein 
hormone that contains four O-linked carbohydrate sites on the β-subunit and 30-35% of 
hCG’s molecular weight is attributed to carbohydrates [12]. The carbohydrates are 
required for biological activity and also regulate the rate of hormone clearance from the 
body. Additionally, carbohydrates can be removed from hCG [15] to yield 
deglycosylated-hCG which binds LHR with the same affinity as hCG but which is non-
functional because there is no activation of adenyl cyclase (AC), a protein that converts 
adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) in the signal 
transduction pathway [16]. In this deglycosylated form of hCG, approximately 94% of 
the carbohydrates are removed by treatment of hCG with anhydrous hydrofluoric acid 
[15, 17].  
 
 LHR also binds LH as well as hCG. The structure of LH involves α- and β-
subunits similar to hCG. The α-subunit consists of 92 amino acids, while the β-subunit 
consists of 121 amino acids [9]. In 1997, Roess and co-workers observed that LHRs 
treated with LH were rotationally mobile on MA-10 cells [18]. Conversely, hCG-treated 
MA-10 cells exhibited LHRs that were rotationally immobile. The results of these studies 
suggest that the extra carbohydrates on hCG can interact with cell proteins creating large 
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molecular weight complexes leading to slower rotational diffusion rates for hCG-
occupied LHR relative to LH-occupied receptors. 
 
Luteinizing hormone signal transduction 
 
 The LHR, like other G protein-coupled receptors or GPCR, activate G-proteins 
which are heterotrimeric proteins consisting of α, γ and β subunits, which generate cell 
signals in response to extracellular ligands. LHR is inactive when there is no hormone 
bound (Figure 3a). Hormone binding activates the receptor (Figure 3b). The Gα subunit of 
the G-protein undergoes an allosteric change and GDP (guanosine diphosphate), a 
nucleotide, is displaced with GTP (guanosine triphosphate) resulting in Gα dissociating 
from the Gγ and Gβ subunits and binding to the receptor in which it interacts with the 3
rd 
intracellular loop [19]. Subsequent activation of adenyl cyclase converts adenosine 
triphosphate to secondary messengers, cAMP, which carries signals to other systems in 
the cell (Figure 3c) [19]. After cAMP is released, a specific mechanism exists to stop 
signaling. ARF nucleotide binding site opener (ARNO) binds to the base motif of the 7th 
domain (Figure 3d), which promotes the displacement of GDP by GTP in ADP 
ribosylation factor 6 (ARF6) [19]. Gα returns to the Gγ and Gβ subunits making the G-
protein heterotrimeric once again. β-arrestin 2, a protein with the ability to stop signal 
transduction, is then released and binds to the 3rd intracellular loop for signal termination 





3a       3b 




Figure 3: Signal transduction pathway of LHR. (a)LHR is inactive when there is no 
hormone bound. (b) LHR is active when there is hormone bound to the receptor. (c) The 
Gα subunit of the G-protein undergoes an allosteric change and displaced with GTP and 
Gα dissociates from the Gγ and Gβ subunits and binds to the receptor. AC is activated to 
convert ATP to cAMP. (d) After cAMP is released, ARF nucleotide binding site opener 
(ARNO) binds to the base motif of the 7th domain, which promotes the displacement of 
GDP by GTP in ARF6. (e) Gα returns to the Gγ and Gβ subunits making the G-protein 
heterotrimeric one again. β-arrestin 2 is then released and binds to the 3rd intracellular 










































































Why study the luteinizing hormone receptor?  
 
There are several reasons to study the luteinizing hormone receptor. One of these 
is the importance of the receptor to mammalian fertility. Signal transduction of LHR in 
both sexes is important for successful reproduction. LHR has natural-occurring mutations 
that result in human diseases. Therefore, a better understanding of the receptor will help 
in understanding such conditions. One example of such a disease is familial male-limited 
precocious puberty (FMPP), which is early puberty in males caused by high levels of 
testosterone. This occurs due to constitutive activity of mutant LHR in the absence of 
hormone, causing testicular tumors arising from prolonged exposure to elevated 
testosterone levels [20]. Other examples of LHR-related diseases occur in women where 
infertility, polycystic ovaries and ovarian tumors can result from hyperandrogenism, 
namely high steroid production attributed to excess LH production [20]. Recently, it was 
also found that increased levels of LH are associated with cognition impairment and 
higher risk of Alzheimer’s disease [21].  
 
 Additionally, the study of LHR is important because G protein-coupled receptors 
(GPCR) represent 50% of targets for new drug development [22, 23]. Thus better 
understanding of GPCRs can lead to new and improved drug therapeutics. Relatively 
little is known about GPCR interactions with protein ligands. Computerized modeling 
approaches are often used in drug design by pharmaceutical companies to determine 
receptor ligands and biological function [22, 24] due to limited experimental information 
on how GPCR interact with ligands on actual cells. Thus, increasing our understanding of 
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the GPCR transduction pathway in actual cells will result in a better understanding of 
structural features that activate receptors and thus lead to more selective receptor 
targeting in drug development. Furthermore, this will lead to new therapeutics including 
those with reduced non-specific drug effects. Examples of GPCRs targeted in the 
pharmaceutical industry are Zyprexa, Claritin and Serevent [24]. Zyprexa targets the 
serotonin 5-HT2 receptor to treat schizophrenia or psychosis. Claritin targets the 
histamine H1 receptor and treats rhinitis or allergies and Serevent targets the β2-
adrenergic receptor and treats asthma.   
 
Models for the plasma membrane 
 
 LHR is a transmembrane protein, therefore it is important to understand the 
nature of the plasma membrane in which it is imbedded. In 1925, lipid arrangement in 
cell membranes was proposed by Gorter and Grendel [25].  In a Langmuir trough at the 
air/water interface, molecular surface areas in monomolecular layers of lipids extracted 
from red blood cells were compared to surface areas of individual red blood cells. From 
their data, they proposed the lipid layer was two lipids thick. Danielli and Davson [25] 
extended this model by adding adsorbed proteins to the external and internal hydrophilic 
surfaces of the membrane layer (Figure 4). 
 
In 1972, Singer and Nicolson [26] proposed the Fluid Mosaic Model to describe 
the organization of the plasma membrane. This model suggests that the plasma 





Figure 4: Diagram of the lipid layer proposed two lipids thick by Gorter and Grendel. 
Danielli and Davson extended this model by adding adsorbed proteins to the external and 






proteins within and sitting atop, respectively, the plasma membrane (Figure 5). The fluid 
mosaic model was distinct from the dynamic model proposed by Danielli and Davson in 
1934. In the fluid mosaic model, the phospholipids have polar heads consisting of ionic 
residues that react with water. The phospholipids’ non-polar hydrocarbon chains face the 
inside of the phospholipid bilayer to interact with each other. The hydrophilic and 
hydrophobic interactions of the phospholipids in an aqueous environment lead to the 
organization of plasma membrane phospholipids in a thermodynamically-stable structure. 
Electrostatic interactions and hydrogen bonding are secondary in the phospholipid bilayer 
organization. Proteins in the phospholipid bilayer are oriented so that their charged and 
polar residues interact with the aqueous environment and the hydrophobic surfaces of 
their amino acid residues interact with the hydrocarbon chains for the phospholipids. 
 
 In 2005, Kusumi and co-workers [27] added that the cytoskeleton, a structure that 
maintains the integrity of the cell membrane, plays a role in regulating lateral diffusion of 
plasma membrane proteins. They observed that lipid and protein diffusion in cell 
membrane is compartmentalized with sub-micron compartment sizes of 32-230 nm and 
that diffusion within a compartment was much faster than diffusion over longer distances, 
i.e. between compartments. The slower diffusion rates were attributed to plasma 
membrane proteins and lipids hopping over the barriers to move to another compartment. 
They termed this “hop diffusion” (Figure 6) and introduced the Compartmentalized Fluid 









Figure 5: Singer and Nicolson’s fluid mosaic model. This model explains that the plasma 
membrane is a two-dimensional phospholipid bilayer with integral and peripheral 














Figure 6: Diagram of Compartmentalized Fluid Model proposed by Kusumi and co-
workers [28]. In this model, the cytoskeleton, a structure that maintains the integrity of 
the cell membrane, plays a role in restricting lateral protein diffusion in the plasma 
membrane. They experimentally observed proteins and lipids hopping over barriers such 




Biophysical studies of membrane molecule dynamics and interactions 
 
 In the 1970s, various groups demonstrated lateral diffusion of molecules within 
the plasma membrane. In 1972, Singer had proposed that proteins and lipids in the 
plasma membrane are capable of lateral and rotational motion [26]. One of the first 
studies demonstrating free diffusion in the plasma membrane was that of Frye and Eddin. 
In 1970 Frye and Eddin [30] used fluorescein isothiocyanate [31] and 
tetramethylrhodamine isothiocyanate (TRITC) to label two antibodies directed against 
surface antigens on human and mouse lymphocytes, respectively. Human and mouse 
lymphocytes were fused by Sendai virus to form heterokaryons which, upon treatment 
with the antibodies exhibited red- and green-fluorescence. With fluorescence microscopy, 
mouse and humans antigens were observed as halves of the plasma membrane after cell 
fusion and, after approximately 40 minutes, they observed a 90% mix occurring. In 1973 
Loor and co-workers [32] found that the plan lectin concanavalin A promoted 
aggregation of membrane proteins on lymphocytes. They saw large clusters or “caps” of 
fluorochrome-labeled glycoproteins after treatment with concanavalin A, a lectin which 
aggregates mannose- and glucose- containing glycoproteins. In addition, Poo and Cone 
[33] monitored absorption after photobleaching of rhodopsin in retinal rod outer 
segments, to observe lateral diffusion of membrane proteins. By this method Poo and 
Cone were able to measure diffusion of rhodopsin in retinal rod outer segments freshly 
removed from frogs and mudpuppy eyes with values of 3.5x10-9 and 3.9x10-9 cm2/sec, 
respectively. In 1974 Peters and co-workers [34] observed lateral diffusion of 3x10-12 
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cm2/sec for FITC-labeled proteins on erythrocytes using an early implementation of 
fluorescence recovery after photobleaching (FRAP).  
  
 In 1976 fluorescence photobleaching recovery (FPR), an improved version of 
Peters et al.’s technique, was developed by Alexrod and co-workers [35] to measure 
lateral diffusion in the plasma membrane. Fluorescently-labeled molecules in a small 
spot, 1-10 µm in diameter are photobleached by a brief pulse of a focused laser beam, 
and the subsequent recovery of the fluorescence is monitored by the same, but attenuated, 
laser beam. Recovery occurs from lateral transport of intact fluorophores from the 
surrounding surface to the bleached spot. This technique also was independently 
developed by Jacobson and co-workers [36] after which FPR became more commonly 
known as FRAP.  
 
FRAP measures both the lateral diffusion coefficient of a molecule and the 
fraction of that molecule that is mobile in the plasma membrane. Both the diffusion 
coefficient and “mobile fraction” reflect the interactions of the protein with other 
membrane molecules and/or structures. FRAP fluorescence recovery intensity can be 
plotted versus time and, from the measured recovery half-time t1/2, diffusion coefficients 







1 =        (1) 
where D is the diffusion coefficient and r is the laser beam 1/e2 radius. The mobile 
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Where F0, Ft, and F∞ represent the pre-bleached fluorescence, the immediate post-bleach 
fluorescence and the fluorescence recovered at long post-bleach times. 
 
Using photobleaching methods, Jacobson and co-workers were able to show that, 
in mouse fibroblast cells treated with fluorescein-succinyl concanavalin A (F-SConA), 
surface proteins exhibited lateral mobility values close to that predicted by theory [36]. In 
1979 Barisas and co-workers [37] performed photobleaching on rabbit lymphocytes. 
Plasma membrane proteins of T cell and B cells were stimulated by succinyl 
concanavalin A (S Con A), a lectin that induces aggregation but not capping as does 
concanavalin A. They observed a decrease over time in the diffusion constant from 
1.6x10-10 to 6.5x10-11 cm2/sec for T cells and from 1.4x10-10 to 5.5x10-11 cm2/sec for B 
cells. Diffusion constants of fluorescently-labeled lipids remained relatively unchanged at 
1.9x10-8 cm2/sec for T cells and 1.5x10-8 cm2/sec for B cells, suggesting receptors with 
lowered lateral motilities do not have a significant effect on the surrounding lipid 
environment. Mobile fractions for cells treated with S Con A were 90% for cells labeled 
with 1,1'-Dioctadecyl-3,3,'3' – tetramethylindocarbocyanine iodide (DiI), a fluorescent 
lipid dye, and 60% for cells treated with tetramethyl rhodamine (TMR) S Con A. Barisas 
and co-workers [38] later demonstrated that laser bleaching and probe beams not focused 
on exactly the same sample location would lead to inaccurate recovery times and 
diffusion coefficients. From theoretical calculations, Barisas showed that beam 
misalignment cannot exceed 0.3 times the 1/e2 beam radius for diffusion coefficients to 
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be within ~10% accuracy. Additionally, Barisas showed that neutral density filters of 
different degrees of wedge can yield diffusion coefficients varying by 3-to 15-fold, 
therefore the same neutral density filter should be retained between experiments. 
 
There are now newer biophysical techniques that complement FRAP in measuring 
lateral diffusion and more complex organization such as protein interactions in the 
plasma membrane with living cells. These include fluorescence correlation spectroscopy 
(FCS) and single particle tracking (SPT). 
 
FCS can measure the number of fluorescent molecules in a defined sample 
volume to probe molecular density and diffusion. FCS uses a small focal volume of 
several femtoliters defined by a laser beam and pinhole to monitor intensity fluctuations 
in a sample over time [39]. The number of observed molecules is low enough so that each 
molecule contributes a substantial amount of measured signal. Fluorophores diffusing in 
and out of the detection area give rise to fluctuations in the emitted signal. From the 
measured intensity, the time autocorrelation function G(τ), which is the measure of the 
signal’s self-similarity, can be defined as   
( )







=       (3) 
where δF(t) is the measured intensity fluctuation about the mean at time t and δF(t+τ) is 
the fluctuation at a later time (τ) from t. From a plot of G(τ) versus correlation time τ, the 
number N of molecules in the illuminated area of the sample can be calculated as 
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where τD is the characteristic time for fluctuation decay. 
 
SPT is also used to measure lateral diffusion coefficients, and domain size 
accessed by, particular molecules. Hence this technique also provides information to 
evaluate protein interactions in the plasma membrane. In SPT, 20-40 nm gold 
nanoparticles are attached to the protein of interest and imaged over time to track protein 
motions [29]. Quantum dots or organic dyes can also be used for labeling plasma 
membrane proteins as can fluorescent proteins such as visible fluorescent protein (VFP) 
constructs. Particle-labeled cells in a microscope are imaged using a CCD camera. To 
analyze SPT data, the positions of the particles are determined for every image in the 
video and mean square displacements (MSD) are calculated [40].  MSD indicates the 
distance a particle travels over time. The definition of MSD is given by Equation 5 
( ) ( ) ( ) ( )( )( )22 ττ +−++−= tytytxtxM    (5) 
where τ is the lag time and x and y are particle coordinates. The brackets in Equation 5 
denote averages over time. Normal diffusion is unrestricted diffusion of the particle 
within the plasma membrane. Anomalous subdiffusion considers effects of components 
in the plasma membrane that interact with the labeled protein to alter the normal linear 
dependence of MSD on time. Confined diffusion could involve immobile proteins, 
proteins with restricted motion from lipid rafts, proteins confined within boundaries 
imposed by the cytoskeleton or proteins tethered to other immobile species. Feder and co-
workers [41] derived theoretical equations for particles moving in different motions in 
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three dimensions. Equation 6 is for normal diffusion, Equation 7 is for anomalous 
subdiffusion, and Equation 8 for directed motion with diffusion in three dimensions [40]. 
( ) ττ DM 6=         (6) 
( ) αττ DM 6=         (7) 
( ) ( )26 υττ += DM        (8) 
where υ is velocity of the particle and D is the diffusion coefficient, τ is lag time, and α is 
a coefficient less than one. Equation 5, mentioned above, is for a 2-dimensional system 
such as lateral diffusion of a cells surface protein. SPT experiments also yield the 
diffusion coefficients [42] as defined by Equation 9. 
τ4
2
rLD =         (9) 
where Lr is compartment diameter and τ is particle residence time in the compartment. 
Figure 7 shows four theoretical curves for various modes of particle motion. Curve I is 
for a protein in active transport corresponding to Equation 5, curve II is for random 
diffusion and corresponds to Equation 6, curve III is for anomalous subdiffusion 
corresponding Equation 7 and curve VI is for a confined protein corresponding to 
Equation 8.   
 
Over the last decade, techniques have been developed to directly image 
fluorescently-labeled proteins in the plasma membrane with resolution sufficient to 
determine protein positions on the scale of molecular dimensions. On example of such a 
technique is stimulated emission depletion microscopy (STED) which provides super-









Figure 7: Mean square displacement versus time curves. (I) protein active transport (II) 
random diffusion (II) Anomalous subdiffusion that considers components in the plasma 
membrane that may interact with the labeled protein (IV) confined protein. From Gratton 
et al. [43]. 
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microscopes. STED uses a doughnut-shaped depletion beam combined with a Gaussian 
probe beam to deplete florescence emission from the outside ring leaving only the central 
fluorescence emission [44] which can be smaller than the Abbe-limit; the spot size that is 
observed for imaging ranges from 30 to 80 nm [44, 45]. Localization microscopy such as 
photoactivated localization microscopy (PALM) and stochastic optical reconstruction 
microscopy (STORM) obtain images with approximately 10 nm localization by using 
intermittent fluorescence from which a super-resolution image can be reconstructed [44]. 
Unfortunately, these techniques require expensive equipment, long experiments and 
complex post-processing.  
 
 Molecular crowding 
 
 A high concentration of proteins in a given area is termed molecular crowding or 
the excluded volume effect because the effective protein concentration is much larger 
than the bulk concentration in that area. Molecular crowding is important because it has 
kinetic and thermodynamic effects on cell membrane molecule behavior. Minton and 
Ross proposed that, in surfaces that are uncrowded, the equilibrium constants and 
reaction rates for surface molecules can differ by orders of magnitude from cells with 
crowded conditions [46, 47]. However, molecular crowding is often overlooked and little 
attention has previously been paid to consequences of varying surface densities of 
membrane receptors [48, 49]. Molecular crowding is significant since some membrane 
proteins normally function at low concentrations but when these proteins are artificially 
expressed in cells, at high concentrations, molecular crowding can change the proteins’ 
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signaling characteristics. Therefore, protein studies concerning oligomerization or 
aggregation should report protein surfaces densities so that possible consequences of 
molecular crowding can be assessed.  
 
 Molecular crowding has substantial effects on reaction equilibria. Ross and co-
workers [50] reported the activity coefficient of hemoglobin as a function of hemoglobin 
concentration (Figure 8a). They demonstrated that the apparent concentration is higher 
than its actual concentration and that the relationship between the activity coefficient and 
hemoglobin concentration is non-linear. This is based on previous calculations that 
macromolecules in the cell occupy 20-30% (200-300 g L-1) of the total volume [51-55].  
Zimmerman [55] reports activity coefficient versus molecular weight for the 
macromolecule chicken egg lysozyme in Escherichia coli (E. coli) cells (Figure 8b). As 
molecular weight increases, the activity coefficient triples as molecular weight 
approaches 3000 g/mol and increases over two orders of magnitude when molecular 
weight approaches 50,000 g/mol, thus demonstrating the effect of molecular crowding on 
thermodynamic activity.  
 
 The significance of molecular crowding is that it promotes self-association of 
proteins by reducing the available cell volume or surface area. This can increase 
association constants by two or three orders of magnitude [49]. Increasing the number or 
size of proteins in a cell lowers the entropy of each protein, thus resulting in an increased 
contribution to total free energy of the surrounding environment [49]. Aggregation is 






Figure 8: Effects of molecular crowding of thermodynamic and kinetic parameters. (a) This curve demonstrates activity 
coefficient versus hemoglobin concentration is non-linear and its apparent concentration is higher than its actual concentration.  
(b) The activity coefficient triples as molecular weight approaches 3000 g/mole and increases over two orders of magnitude 
when molecular weight approaches 50,000 g/mole, thus demonstrating the effect of molecular crowding on thermodynamic 
activity. (c) For a reaction, A +B ↔ AB* ↔ AB (where AB* is the transition state) the reaction is diffusion-limited (green 






association occurs because low free volume causes an increase in effective concentration 
which drives aggregation. After aggregation, there may be a slight increase in available 
volume which lowers total free energy of the surrounding environment. 
 
 Additionally, reaction rates are affected by molecular crowding. A biological 
system becomes diffusion-limited at very high surface densities because there are more 
proteins blocking the protein’s path from one point to another. Zimmerman and Minton 
[55] graph a theoretical curve (Figure 8c) showing the log of reaction rate versus 
crowding agent or fractional volume occupancy. The graph shows that, for a reaction, A 
+B ↔ AB* ↔ AB (where AB* is the transition state), the reaction is diffusion-limited 
(green curve) or transition state limited (blue curve) and the overall reaction is limited by 
molecular crowding (red curve).  
  
 The relevance of molecular crowding to actual biological phenomena varies 
widely among cell systems. Some endogenous membrane proteins, such as the Type I Fcε 
receptor appear naturally at very high surface densities [56]. Others, such as peptide 
hormone receptors including LHR, are typically expressed at relatively low levels [57] so 
that molecular crowding would thus be expected to have limited significance to their 
normal biological function. However, difficulties can arise when such normally sparsely-
expressed receptors are artificially expressed in cells by transfection. This process begins 
by transient transfection which produces a cell population which typically contains a very 




Cell transfections can be used to study a protein of interest on cells that are easier 
to maintain than on cells where it is naturally expressed. Alternatively, transfection can 
be used to provide cells expressing a genetically modified protein or to provide a 
fluorescent, form of a protein that cannot be labeled via fluorophore conjugation. This 
can provide intrinsically fluorescent proteins. Transient transfection is a rapid technique 
that only takes 1-2 days for optimal expression, depending on the DNA and the cell type. 
However, this type of transfection may lead to high and varying expression levels since 
the cells take up varying amounts of DNA and so express various receptor numbers. 
 
Stable transfections follow from transiently transfected cell samples. The 
transfected DNA is integrated into the chromosome and thereby stably expressed from 
generation to generation. After DNA is cultured with cells for 24-48 hours with a 
transfecting agent in a petri dish, the cells are moved to a culturing flask. Cells are 
cultured with the only disturbance being when a fresh change of media as needed. The 
media contains geneticin which is an antibiotic that allows only cells that have taken up 
particular DNA to live. A typical geneticin concentration amount in media for CHO cells 
is 400 µg/mL. The initial stable cell line selection can take anywhere from one to two 
weeks at which time, after a massive cell death, only successfully-transfected cells 
remain.  
 
 A transfected cell colony can be selected from the culture flask with a 
micropipette, and plated into a 24-well petri dish. After the cells in the wells reach 
approximately 90% confluency, which may take up to 10 days, a (hopefully) monoclonal 
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sample from a well is transferred to a 6-well petri dish and recloned. Alternatively, a cell 
line can be started from one cell in a 96-well petri dish.  A hemocytometer or flow 
cytometry can be used to achieve a suitable dilutions giving one cell per well. To use a 
hemocytometer, the number of cells in a microscopic volume square of known 
dimensions, such as 106 µm3, is counted to obtain the number of cells per mL. The 
appropriate volume is then calculated for one cell per well and added to a 96-well petri 
dish. When 90% confluency is reached in the 6-well dish, the cells are transferred to a 
new culture flask to grow. The 6-well petri dish culturing can take up to 14 days to for 
90% confluency. The more common technique is to use flow cytometry, a technique 
measuring fluorescence intensity exhibited by individual cells in a population, to 
electrostatically sort cells in a petri dish and to determine receptor density in the cell 
population. 
 
 In any case, often it is the most highly expressing cells which are examined 
directly in transiently transfected cells or which are selected for cloning into stable cell 
lines. Receptors in such highly-expressing cells may thus exhibit significant molecular 
crowding effects which would be completely irrelevant to the physiology of receptors 







Fluorescence resonance energy transfer and bioluminescence resonance 
energy transfer 
 
The aggregation states of LHR after various cell treatments and in LHR mutants 
have been matters of considerable interest [18, 58-67]. Fluorescence resonance energy 
transfer (FRET) is a biophysical phenomenon by which distances between specific 
molecules can be evaluated and gives rise to the most powerful current methods for 
identifying intermolecular interactions on intact cells. FRET can be measured through 
steady state or time-resolved fluorescence measurements using fluorescently labeled 
molecules. FRET was first observed by Perrin in 1926 [68]. Perrin observed reduced 
polarization of uranin in glycerol as uranin concentration was increased. Reduced 
polarization was due to energy transfer manifested by practically randomized orientation 
of the acceptor excited state. In 1948, Förster proposed long range molecular interactions 
between chromophores and derived equations relating spectroscopic properties of 
fluorophores to interchromophore distance [69]. Förster calculated that resonance energy 
transfer occurs when there is dipole coupling between the donor and acceptor 
fluorophores. FRET efficiency (E) depends on the inverse sixth power distance (r) 



















E        (10) 
In Equation 10, ro is the distance where FRET efficiency is 50%, also called the Förster 
distance, and is defined as 
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[ ] 612423 )(108.8 λκ JQnro −−×=       (11) 
where n is the refractive index of the medium, Q is the quantum yield of the donor in 
absence of the acceptor, κ
 
is the orientation factor of the two dipoles, and J(λ) is the 
spectral overlap. κ
 
depends on the orientation of the donor and acceptor dipoles (Figure 9) 
and is defined by 
[ ]DAT CosCosCos θθθκ ×−= 3
2      (12) 
where θT is the angle between donor and acceptor transition dipole moments and θA and 
θD are the angles between the separation vector, r. Kappa can vary from 0 to 4 but is 
usually taken to be 2/3, which is an average for all the possible angles between the donor 
and acceptor transition dipoles. J(λ) is defined by 






=      (13) 
which is the integral between the donor fluorescence intensity FD(λ) and the overlapping 
acceptor excitation spectrum EA(λ).  
 
In 1951, Weber [70] examined FRET effects on fluorescence polarization. BSA 
and ovalbumin were conjugated with dansyl groups and fluorescence intensity was 
measured for each conjugate in phosphate buffer. Within experimental error the 
depolarization of both BSA and ovalbumin conjugates agreed with Perrin’s theoretical 

































Figure 9: Dipole-dipole coupling in FRET where θT is the angle between donor and 
acceptor transition dipole moments and θA and θD are the angles between the separation 
vector, r and the acceptor and donor transition dipoles, respectively. Adapted from Rao  
and Mayor [71].  
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where P is observed polarization, Po is intrinsic polarization, τ is the excited state lifetime 
and ρ is the Debye rotational relaxation time. In 1961, Dandliker and Feigen [70] 
developed the first polarization immunoassay. Fluorescein isothiocyanate [31] was 
conjugated to ovalbumin and antibodies that bind ovalbumin were raised to FITC-
ovalbumin. Fluorescence polarization intensity was measured to detect formation of the 
antigen-antibody complex. Haber and Bennett [71] used fluorescence anisotropy to study 
FITC-insulin, FITC-ribose nucleic acid (RNA), and FITC-BSA binding to their 
respective antibodies in 1962. In this study, they found that, when FITC was excited with 
a 495 nm laser, compared to the 436 nm laser used by Dandliker and Feigen, the 
observed polarization was lower. This suggested that excitation wavelength could affect 
polarization values.  
 
Stryer and co-workers [72] verified Förster’s theory by measuring energy transfer 
between a naphthalene donor and a 1-dimethylanimonaphthalene-5-sulfonyl chloride 
(dansyl) acceptor using  poly-L-proline oligomers to separate them at known distances 
ranging from 12-46 Å. Energy transfer efficiencies ranged from 16 to 100%, as distances 
between donor and acceptor molecules decreased. They observed an inverse 5.9±0.3 
power dependence for FRET between donor and acceptor fluorophores which was in 
agreement with Förster’s theory. Stryer proposed that FRET can be used as a 
spectroscopic ruler to determine distances between biological species [72]. In 1967, Kuhn 
and co-workers [73] also demonstrated there was an inverse six power dependence in 
FRET using by multilayers of fatty acids of known dimensions to separate cyanine dyes. 
In 1969, Haugland and co-workers [74] showed that the energy transfer rate depicted by 
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Förster reflects the overlap J between the fluorescence donor emission and acceptor 
absorbance. They used the rigid steroid 1'-methylindolo (3',2':2, 3)-2(5α)-androsten-17-
one which has an N-methylindole donor group at one end of the molecule and a ketone 
group acceptor, at the other end. The distance between the donor and acceptor was 10.2 
Å. Transfer rates were obtained using a nanosecond fluorimeter and excitation/emission 
spectra were recorded with a spectrofluorimeter as the rigid indole steroid structure was 
placed in solvents of varying polarity. As the solvent polarity increased, the transfer rate 
decreased and the donor emission shifted to the red while the acceptor emission shifted 
slightly to the blue. They observed that J varied by a 40-fold range as the solvent polarity 
increased. An advanced instrument to measure fluorescence polarization was developed 
by Spencer and co-workers [75] in 1973. It is described as an automated flow-cell 
polarization fluorometer. The flow-cell polarization fluorometer was mainly used to 
measure fluorescence polarization in studies of the enzyme-inhibitor or antigen-antibody 
interactions. 
 
In practice, fluorescence resonance energy transfer can be measured between 
proteins on the surface of intact cells. The proteins of interest are labeled with 
fluorophores, where one is the donor and the other the acceptor. For energy transfer to 
occur there must be overlap between the donor emission and the acceptor excitation 
spectra. When an excitation source excites the donor and when both proteins are in close 
proximity, 1-10 nm, there is non-radiative energy transfer from donor to the acceptor. 
The acceptor fluorescence emission is monitored. FRET is typically performed in a 
fluorescence microscope, equipped with using an arc lamp or laser for an excitation. Two 
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types of microscopes are used namely, wide-field and confocal microscopes. The key 
difference is that confocal microscopy uses an aperture placed before the detectors which 
rejects light above and below the focal plane yielding a sharper image compared to wide-
field microscopy. A confocal microscope thus images a single plane in a 3-dimensional 
sample. 
 
FRET experiments using two different types of fluorophores, such as cyan (CFP) 
and yellow fluorescent protein (YFP), are called hetero-FRET. YFP is a highly 
fluorescent protein commonly fused to plasma membrane proteins. YFP is a variant of 
green fluorescent protein (GFP) found in jelly fish Aequoria victoria [76], shown in 
Figure 10. The overall structure of GFP involves of 11 β-strands and short segments of α-
helices that form caps on the top and bottom of the cylinder structure [76]. To increase 
florescence intensity in experiments, enhanced green fluorescent protein (eGFP) and 
enhanced yellow fluorescent (eYFP) were constructed from wild type GFP and YFP, 
respectively. Enhanced YFP (eYFP) differs from GFP by having a threonine residue 203 
(Thr203) positioned near the chromophore which causes a shift in excitation and 
emission spectra (Figure 11). For eGFP and eYFP, the excitation maxima are 484 nm and 
514 nm, and the emission maxima are and 507 nm and 527 nm, respectively. The 
fluorescent form of these proteins arises when tyrosine 66 (Tyr 66) is oxygenated, 
causing serine 65 (Ser 65) and glycine 67 (Gly 67) to undergo rapid cyclization [76], 
Figure 12. The π-π* and n-π* transitions in the aromatic ring are the source of protein 









Figure 10: Two views of the GFP structure. The molecule GFP consists of 11 β-strands 
and short segments of α-helices that form caps on the top and bottom of the cylinder 












Figure 11: Structure of eGFP and eYFP. Enhanced YFP (eYFP) differs from GFP by having a tyrosine residue at 
position 203 (tyr203) near the chromophore which causes a shift in excitation and emission spectra. Adapted from 












Figure 12: Fluorescent form of GFP. Fluorescence occurs when tyrosine 66 (try66) is oxygenated causing serine 65 (ser 65) 
and glycine 67 (gly 67) to undergo rapid cyclization. From Krishna and Ingole [76]. 
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proximity, namely less than 10 nm [77], energy is transferred non-radiatively to YFP.  
YFP will then fluoresce at 527 nm (Figure 13a). 
 
Acceptor depletion FRET is commonly used to analyze hetero-FRET data. In this 
method, cells with acceptor and donor fluorophores are examined before and after the 
acceptor fluorophores are bleached away. Donor emission is measured before and after 
acceptor photobleaching and percent energy transfer efficiency (E) is defined by 




















−=       (15) 
where FAD is the fluorescence emission of the donor in the presence of the acceptor and 
FD is the fluorescence emission of the donor in the absence of the acceptor. Hetero-FRET 
can be used to observe interactions between the same or different proteins. 
 
Another approach to evaluating FRET is through fluorescent lifetime 
measurements but this method requires time-correlated single photon counting methods. 
Percent energy transfer efficiency (E) is calculated using 




















      (16) 
where τAD is the florescence lifetime of the donor in the presence of the acceptor and τD is 
the fluorescence lifetime of the donor in the absence of the acceptor. The advantage with 
this technique is measurements do not depend on the intensity of fluorescence and are 








Figure 13 a-b: There are two types of FRET, hetero-FRET and homo-FRET. In hetero-FRET two different types of 
fluorophores are used, such as cyan (CFP) and yellow fluorescent protein (YFP). CFP can be excited at 457 nm laser source 
and when YFP is close, less than 10 nm, energy is transferred non-radiatively to YFP.  YFP will then fluoresce at 527 nm. In 
homo-FRET the same fluorophore, for instance YFP, acts as both donor and acceptor. A 488 nm excitation source can be used 






approach can be implemented in a microscope to yield fluorescence lifetime imaging 
microscopy (FLIM). Both hetero-FRET and homo-FRET can be analyzed using FLIM 
imaging. 
 
BRET is a variant of FRET that can be performed on intact cells or cell lysates 
[77]. Here, a bioluminescent enzyme donor, Renilla luciferase, is used which produces 
light upon chemical stimulation from a compound such as coelenterazine. The acceptor is 
a construct of YFP or GFP. BRET1 refers to Rluc and YFP construct while BRET2 refers 
to Rluc and a GFP construct, the superscripts in BRET1 and BRET2 being parts of the 
method name, not indications of powers. BRET2 with GFP2 is most popular due to a 
BRET2 has separation of 115 nm from the Rluc emission peak compared to the YFP 
having a separation from Rluc of 55 nm. GFP2 is a mutant of GFP that excites at 400 nm 
instead of 485 nm. This greater separation in Rluc and GFP2 fluorescence emission 
allows easier isolation of GFP2 fluorescence emission. BRET is commonly performed in 
a microplate luminometer. For experiments, saturation assays are used, where BRET 
signal is measured for samples where the donor is held constant and the acceptor ratio 





B =         (17) 
where FA is acceptor emission and FD is donor emission. To analyze data, BRET signal is 
graphed as B versus acceptor/donor ratio. The amount of acceptor required at half-
maximal BRET (B50) for a given donor amount reflects the relative affinity of the 
acceptor/donor pairs. BRET cannot distinguish between dimers and oligomers. B50 values 
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Homo-FRET is the second type of FRET also termed energy migration FRET 
(emFRET) or polarization FRET. Three years after Förster introduced FRET, Gregorio 
Weber [70] examined FRET effects on polarization fluorescence leading to the technique 
now termed homo-FRET. Homo-FRET represents energy transfer between two identical 
fluorescent probes and is now used to determine the aggregation state of plasma 
membrane proteins. In homo-FRET, as opposed to hetero-FRET, only one fluorophore is 
used. This allows easier labeling; hence, it is well-suited to observing self-association of 
a protein. This method requires a fluorophore with small Stokes shift between absorption 
and emission peaks, such as that exhibited by YFP, and is based on the polarization of 
emitted fluorescence. If one considers fluorophores with randomly-oriented transition 
dipoles (Figure 14a) being excited with polarized light, photoselection occurs (Figure 
14b). The probability of a fluorophore absorbing light is proportional to cosine squared of 
the angle θ between the direction of exciting light polarization and the absorption 
transition dipole [71]. These excited fluorophores transfer energy to nearby acceptor 
fluorophores with a probability proportional to the square of cosine of the angle γ 
between the donor emission transition dipole and the acceptor absorption transition 
dipole and FRET can be observed (Figure 14c). This re-emitted fluorescence has reduced 
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polarization because the emission dipoles can be differently oriented with respect to the 
polarization of exciting light (Figure 15).  
 
Since only one type of fluorophore is involved and since all such molecules are 
equivalent, homo-FRET does not affect emission intensity. However, homo-FRET does 
partially depolarize acceptor emission. This depolarization is measured by anisotropy 
(Equation 13). Anisotropy r is calculated from emitted fluorescence intensities I║ and I┴, 











        (18) 
 
Since, I║ and I┴ light are measured in separate channels which typically have different 
detection efficiencies, a correction factor called the g-factor (G) [78], which is the ratio of 
the sensitivities of the detection system for ║- and ┴- polarized fluorescence, 





G =         (19) 
 
where IVV is the fluorescence intensity observed for excitation and emission polarizers 
both oriented vertically with respect to the laboratory axis and IVH is the intensity 
measured for excitation and emission polarizers vertically and horizontally oriented, 













Figure 14: Polarization of fluorescence. (a) fluorophores with randomly oriented 
transition dipoles (b) when fluorophores with randomly oriented transition dipoles are 
excited with polarized light a subset of the molecules oriented parallel to the polarization 
of the exciting light are excited, photoselection (c) These excited fluorophores transfer 










































Figure 15: Fluorescence emitted after homo-FRET events has reduced polarization 
because the emission dipoles can be more extensively randomized with respect to the 













       (20) 
and, as the fluorophores are irreversibly photobleached away over time, an increase in 
anisotropy is observed. This is because, as fluorophores are irreversibly photobleached, 
the density/proximity of fluorophores decreases. Thus, anisotropy increases as 
photobleaching proceeds because fluorophores are getting further apart. In the limit of 
complete bleaching the measured anisotropy approaches that of a single fluorophore. In 
practice, cells labeled with YFP are bleached to 1-10% of their initial fluorescence with a 
polarized light source. Simultaneously, parallel and perpendicular fluorescence emission 
is monitored so anisotropy r can be calculated. To analyze the data anisotropy upon 
photobleaching versus normalized intensity an example is shown in Figure 16. FRET 










r        (21)  
where r0 is an intrinsic anisotropy of a single fluorophore and r is the measured 
anisotropy for a group of fluorophores. Equation 21 assumes there may be energy transfer 
among donor species, that energy transfers do not return to the same donor and that the 
donor lifetime does not change [79]. 
 
Lipid rafts and techniques for study 
 
Previous reports demonstrate that LHR is associated with lipid rafts [58, 59]. 
Lipid rafts (Figure 17) are plasma membrane microdomains enriched with cholesterol 
and sphingomyelin (Figure 18) and are signaling platforms that range in size from 10-200 
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nm [80]. The current model for raft-mediated receptor signaling is that receptors partition 
into rafts upon hormone activation and there aggregate. Other receptors that have been 
shown to be associated with lipid rafts are the epidermal growth factor (EGF), insulin and 
FcεRI [81]. Raft microdomains are held together by strong van der Waals interactions 
[82]. Raft sphingolipids have a saturated hydrocarbon chain that interacts with the steroid 
ring in cholesterol through hydrogen bonding between the amide groups in sphingolipids 
and the OH groups in cholesterol [83, 84]. Concentration of LHR in lipid rafts could also 
promote aggregation of those receptors. This concentration could be facilitated by 
cytoskeleton compartmentalization of the plasma membrane. Receptor oligomers could 
be confined to a cytoskeletally-defined compartment or could interact with proteins 
tethered to the cytoskeleton (Figure 19).The factors governing LHR partitioning into lipid 
rafts are not well understood. After hormone activation, the receptor could undergo a 
conformational change causing it to interact more strongly with cholesterol and 
sphingolipids. 
 
Alternatively, LHR could oligomerize to yield oligomers having enhanced affinity 
for lipid rafts. If LHR oligomerizes before lipid raft association, this could either arise 
from coiling of the intracellular domain after a hormone binding-induced conformational 
change or from receptors being constitutively dimerized. In addition, the carbohydrates 
on the receptor could form intermolecular hydrogen bonds with other receptors when 






Figure 16: An example of how homo-FRET data is plotted. For homo-FRET data, 
anisotropy upon photobleaching versus normalized intensity is plotted for data analysis. 
The density/proximity of fluorophores decreases as fluorophores are irreversibly 
photobleached. Hence, anisotropy increases as photobleaching proceeds because 
fluorophores are getting further apart. 


























Figure 17: Diagram of plasma membrane components associated with lipid rafts. From 



























Figure 18. (a) Cholesterol structure (b) Sphingomyelin structure. Hydrophobic 
moieties of cholesterol and sphingomyelin interact to form lipid rafts in the plasma 










Figure 19: Compartmentalization of the plasma membrane by the cytoskeleton could also 
promote aggregation of LHR. Oligomers could be confined to a compartment or could 
interact with a protein tethered to the cytoskeleton. (a) no compartmentalization and (b) 















Isolation of detergent resistant membrane fragments (DRMs) is commonly used to 
determine if a particular receptor is present in lipid rafts [86]. A non-ionic detergent such 
as Triton X-100 is used along with density gradient centrifugation. Cell lysates in 
detergent are subjected to gradient centrifugation and the DRMs move within sucrose 
density gradients and translocate to rafts. The low density fractions contain the more 
buoyant lipid rafts and can be analyzed by western blotting to identify the receptor of 
interest. A difficulty with this technique is that receptors many translocate to rafts as a 
consequence of detergent treatment rather than being constitutively present in rafts. 
FRET is a more straightforward approach for these studies. Unlike density gradient 
ultracentrifugation, FRET is applicable to receptors in vivo. To determine lipid raft 
association with the protein of interest, a marker for lipid rafts is labeled with an acceptor 
fluorophore and the receptor with a fluorescent donor. Presence of the receptor in rafts is 
then indicated by hetero-FRET between the fluorescent donor receptors and acceptor raft 
lipids. Ganglioside GM1 can be labeled by B subunit of cholera toxin conjugated with a 
fluorophore. Another acceptor labeling method is afforded by fluorescently labeling a 
GPI-anchored protein. These species are plasma membrane proteins with a glycolipid 
attached to the protein via a carbohydrate chain and have been shown to associate with 
lipid rafts [87]. A third method is to employ lipids covalently conjugated with fluorescent  
probes such as the BODIPY fluorophore. Such fluorescent lipid derivatives include GM1 
and various cholesteryl derivatives. 
 
Recently Loew and co-workers [88] have shown that di-4-ANEPPDHQ, a 
membrane-staining dye, exhibits spectral differences when situated in lipid-ordered and 
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lipid-disordered regions of the plasma membrane. Lipid-ordered regions include lipid 
rafts because the structure of raft domains is rigid compared to the rest of the plasma 
membrane. Lipid-disordered regions include non-raft regions. The maximal possible 
spectral shift in di-4-ANEPPDHQ fluorescence emission maxima is 60 nm between lipid-
ordered and lipid-disordered regions.  
 
Receptor aggregation and lipid rafts in luteinizing hormone receptor 
signaling 
 
Many GPCRs function as dimers or oligomers for cell signaling when hormone or 
other ligand binds the receptor. An example is the Type I Fcε receptor (FcεRI) [89]. In 
the past, the LHR also appeared to oligomerize when hormone was bound. However, 
some recent data has been interpreted to suggest that these LHRs may be oligomerized to 
some extent in the endoplasmic reticulum (ER) and trafficked to the plasma membrane 
where they remain oligomers. Therefore, the actual aggregation states of unliganded and 
liganded LHR remain uncertain. 
 
Three techniques are commonly used alone, or in conjunction with the dynamic 
techniques mentioned above, to determine interactions between specific proteins. These 
techniques are co-immunoprecipitation, FRET and BRET. These latter techniques will be 
described in a subsequent separate section. In co-immunoprecipitation, cells are co-
transfected with proteins containing two epitope tags, genetically-introduced protein 
sequences that can be recognized by specific antibodies. Cells are lysed and the lysate 
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centrifuged. Two antibodies are selected that exclusively bind each protein of interest. 
One or another of these antibodies is used to precipitate proteins bearing the particular 
epitope. The mixture is then centrifuged to isolate complexes from the mixture and gel 
electrophoresis performed to separate the proteins. The proteins from the gel are 
transferred to nitrocellulose paper, incubated with antibodies specific for the epitope-
tagged protein of interest. This is termed a “western blot”. This process is then repeated 
for the other epitope-tagged protein of interest. If both proteins appear at the same 
location on their respective blots, it provides evidence of protein interaction. Western 
blots can be calibrated by obtaining a control using pre-stained molecular weight 
standards. The disadvantage of co-immunoprecipitation is that cells have to by lysed 
prior to running the western blot which may disrupt less thermodynamically stable 
interactions. 
 
Constitutive oligomerization of MHC class II molecules  
 
Major Histocompatibility Complex class II receptors are transmembrane receptors 
associated with antigen-presenting cells such as B cells, macrophages, and dendritic cells 
[91]. These receptors are essential to cellular immune responses. When there is an 
infection in the body, MHC class II molecules present antigens, foreign molecules in the 
body that trigger immune responses, to T helper cells. B and T cells are groups of white 
blood cells also known as lymphocytes. T helper cells activated by antigen release 
lymphokines, chemical that help regulate immune responses. Other cells such as 
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phagocytes, which ingest and kill antigens, are then sent to the area of infection to create 
inflammatory response destroying antigens present from the disease [91]. 
 
The MHC class II molecule is a αβ-heterodimer (Figure 20). The α-chain in class 
II is 33-35 kDa [91, 92]. The β-chain is 25-30 kDa [91, 92]. Class II molecules are 
synthesized in the ER along with an invariant chain (Ii) and directed to MHC class II-
containing compartments (MIIC) where Ii is degraded for antigen binding. Ii is a 
transmembrane glycoprotein that helps regulate antigen presentation [91, 93]. Antigens 
can enter the cell expressing class II molecules via endocytic mechanisms, entering 
endosomal compartments with distinct composition and functional properties (Figure 21). 
The antigens are transferred to MIIC where the class II molecules are located. The class 
II molecules acquire antigens in MIIC compartments and when trafficked to the cell 
surface they present the antigens.  
 
 Past experiments suggest indirectly that Major Histocompatibility Complex class 
II receptors may aggregate, [94-97] to form four-chain (αβ)2 species. Since class II 
molecules already exist as αβ-heterodimers, such putative cell-surface aggregates are 
called “dimers of dimers” or “super-dimers” [98, 99]. Homo-FRET experiments provide 
an opportunity to directly resolve the question of whether MHC class II molecules are 










Figure 20: The MHC class II molecule is a αβ-heterodimer. The α-chain in class II is 
34,000 Daltons. The β-chain is 28,000 Daltons. MHC class II has a molecular mass of 







Figure 21: Class II molecules are synthesized in the endoplasmic reticulum with an invariant chain and directed to MIICs 
where Ii is degraded for antigen binding. Antigens can enter the cell expressing class II molecules via endocytic mechanisms, 
entering endosomal compartments with distinct composition and functional properties. The antigens are transferred to MIIC 
where the class II molecules are located. The class II molecules acquire antigens in MIIC compartments and, when trafficked 





Previous work in our group has suggested that LHR on untreated cells exists as 
monomers located in the bulk membrane. However, upon hormone binding, or for certain 
mutants, receptors exist as aggregates located in lipid rafts [18, 58-67]. However, recent 
work using BRET measurements on LHR expressed by transient transfection have 
suggested that wild type LHR may be constitutively associated in the absence of 
hormone. The overall goal of this dissertation is to suggest how these discordant results 
might be reconciled. 
 
Transient transfections are commonly used in cell experiments to examine 
proteins on live cells. This fast technique takes 1-2 days depending on available DNA 
and cells for optimal expression. However, this type of transfection leads to high 
expression of the DNA, possibly inducing molecular crowding that can alter signaling 
events. Therefore, if a technique such as FRET or BRET is used to determine self-
association of a receptor, the FRET/BRET phenomenon may arise from molecular 
crowding and not from specific receptor interactions.  
 
Moreover hormone-binding LHR have in the past have been found localized in 
lipid rafts [81]. Since rafts which can cover 2 to 30% of the plasma membrane [102, 103], 
local receptor concentrations may be substantially higher than expected based on overall 




 This dissertation presents studies of possible self-association of LHR expressed 
on Chinese Hamster Ovary cells (CHO) cells as examined primarily by homo-FRET. The 
overall motivating goal is to determine whether the apparent receptor association 
observed in previous FRET and BRET measurements may represent molecular crowding 
rather than specific receptor aggregation into dimers or higher oligomers. The following 
specific questions are addressed: 
1. Is there evidence for apparent association of LHR on untreated cells and do 
hormones affect this apparent association? 
2. Do different receptor expression levels on individual cells affect apparent receptor 
association? 
3. Do transfected cells exhibit a range of receptor expression levels? What numbers 
of receptors per cell might strongly-expressing cells possess? 
4. Does theory suggest that LHR numbers measured in transfected cells could cause 
substantial apparent FRET/BRET simply through molecular crowding? 




Methods and Materials 
 
 Materials. Dr. George R. Bousfield, from the Department of Biological Sciences 
at Wichita State University, kindly provided human chorionic gonadotropin (hCG) and 
deglycosylated-hCG. Human chorionic gonadotropin was also purchased from Fitzgerald 
Industries (Acton, MA).  Chinese Hamster Ovary cells were purchased from American 
Type Culture Collection (Manassas, VA). Dulbecco’s Modified Eagle medium (DMEM) 
and geneticin were purchased from Cellgro (Manassas, VA). Penicilin/streptomycin, L-
glutamine solution, and Benchmark fetal bovine serum (FBS) were purchased from 
Gemini-Bio-Products (West Sacramento, CA). 100 x MEM non-essential amino acid 
solution, bovine albumin and ethylenediaminetetraacetic acid (EDTA) were purchased 
form Sigma-Aldrich (St. Louis, MO). Lipofectamine 2000 reagent was purchased from 
Invitrogen (Carlsbad, CA). Quantum FITC MESF (molecules of equivalent soluble 
fluorophore) beads were purchased from Flow Cytometry Standards Corporation (San 
Juan, PR). WillCo Wells glass bottom cell culture dishes with 35 mm diameter and 12 
mm diameter glass bottoms were purchased from Warner Instruments (Hamden, CT).  
 
 Cell lines. CHO cells transiently transfected were prepared with 1.6 µg of hLHR-
eYFP, kindly prepared by Ying Lei, Department of Physiology at Colorado State 
University, using Lipofectamine 2000 in accordance with Manufacturer’s instructions. 
Two microcentrifuge tubes each containing 100 µL of complete CHO media, outlined 
below without geneticin, had 1.6 µg of hLHR-eYFP in one microcentrifuge tube, 4 µL of 
Lipofectamine 2000 in the other microcentrifuge tube and they were incubated at room 
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temperature for 5 minutes. The two microcentrifuge tubes containing the DNA and 
lipofectamine are mixed together into one tube and incubated at room temperature for 30 
minutes. This volume is then added to the cells in 35 mm petri dishes. Transfection 
proceeds for 41-43 hours. After transfection, cells were imaged or treated with hormones. 
Transfected cells were maintained in Dulbecco’s Modified Eagle medium (DMEM) with 
10% FBS, 1% P/S, 1% L-glutamine, 1% 1x non-essential amino acids and 200 µg/mL of 
geneticin. Untransfected CHO cells were maintained in the same media above but 
without geneticin. All cells were maintained in 5% CO2 at 37°C.  
 
 Sample preparation for homo-FRET. After cells were 80-90% confluent in a 25 
cm2 culture flask, cells were incubated with 5 mM EDTA for 3 min and 0.5-1.0 mL of 
cells were plated in a 35 mm glass bottom petri dish. After 4 hours or overnight culture, 
the cells were transiently transfected. Cells were washed twice with 1xPBS and 
immediately imaged as described below.  
 
 Sample preparation for flow cytometry. Cells were grown to 80-90% confluence 
in a 25 cm2 culture flask. Next, cells were incubated with 5 mM EDTA for 3 min in that 
same culture flask and the flask was partly washed with 3 mL of 1xPBS. The 3 mL of 
cell suspension was then placed in a 15 mL centrifuge tube analyzed using the MOFLO 
Flow Cytometer and High Speed Cell Sorter (Dako Colorado, Inc) with Quantum FITC 
Molecules of Equivalent Soluble Fluorophores (MESF) bead standards at Colorado State 
University Department of Environment and Radiological Health Sciences flow cytometry 
facility. The beads are 7.2 µm in size. The MESF values for the blank, bead standard 1, 
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bead standard 2, bead standard 3 and bead standard 4 are 0, 33024, 109996, 317482 and 
1580198, respectively. Fluorescence intensity was collected using a 488 nm argon ion 
laser as an excitation source, a 530/30 nm emission filter and the amplifier operating in 
the logarithmic mode.  
 
 Homo-FRET measurements. The Förster distance for the YFP-YFP donor-
acceptor pair is 5.11 nm [104] so that energy transfer between such chromophores occurs 
only when donor-acceptor pairs are 1-10 nm apart. Homo-FRET data were collected on 
the Olympus FV300 confocal laser scanning microscope. Fluoview software allows 
visualization of cells during experiments. Fluorescence emission was collected using a 
488 nm argon ion laser to bleach the cells to ~10% of initial fluorescence within 
approximately 30 images. Parallel and perpendicular fluorescence emission images, with 
respect to polarization of exciting light, were collected simultaneously using a polarizing 
beam splitter that is directly placed in front of the photomultiplier tubes (PMTs) (Figure 
22). A 535/50 nm emission filter was used to isolate YFP fluorescence. A 300 µm 
confocal aperture placed directly in front of the polarizing beam splitter (Figure 22) was 
used. The confocal aperture provides z-axis resolution by rejecting light above and below 
the focal plane. All cells were focused on the equatorial plane, which appear as a ring-
like shape (Figure 23). Cells were bleached for 2-3 minutes while being imaged with one 
cell per image. Images for g-factor calculation were acquired by lowering transmitted 
light until both the parallel and perpendicular channels were medium-gray, namely about 
2000 units of a maximum of 4095. Background images were taken by completely 













Figure 22: Light path for FV300 Confocal Scanning microscope. There are three 
channels to monitor parallel, perpendicular emission and transmitted light images. An 
emission barrier filter is placed before aperture turret which, in turn, is located in front of 







Figure 23: Confocal images of a CHO cells transfected hLHR-YFP and photobleached 
during homo-FRET. The two images on the top are perpendicular fluorescence emission 
polarized perpendicular to the excitation polarization and the two images on the bottom 
are florescence emission polarized parallel to the excitation polarization. The images on 
the left are when photobleaching begins and on the right where photobleaching ends. The 
bottom picture is the transmitted light image of the cell. 






10 µm 10 µm




a black cap. Background and g-factor images were analyzed in Adobe Photoshop 7.0. 
Background was subtracted from fluorescence emission images and g-factor was applied 
to correct for different sensitivities that arise from the two PMT detectors. G-factor is 
calculated using Equation 19. Masking of the cells was performed in Adobe Photoshop 
7.0 to isolate the ring-like membrane fluorescence. The brush tool with a diameter of 9 
pixels was used. Masking allows for analyzing only the fluorescence emission from the 
cell membrane and rejecting out-of-focus cytoplasmic fluorescence. Using a custom 
analysis program, background was subtracted from each image and anisotropy calculated 
using Equation 21. The intrinsic anisotropy, which is the anisotropy value of a single 
isolated eYFP fluorophore, was set to 0.35 for all cells, close to the value Clayton and co-
workers [23] assumed for eYFP. For each petri dish, 10-20 cells are analyzed. 
 
Flow cytometry data analysis. To determine the range of receptor numbers on 
transfected cell populations, FITC fluorescence signal intensities measured in cytometer 
for Quantum MESF beads needs to be related to signals measured for hLHR-eYFP on the 
cell surfaces. In a Quantum MESF kit, each microsphere population is assigned a value 
corresponding to the number of FITC molecules in solution which give a same signal as 
the bead. For example, a Quantum FITC microsphere with an MESF value of 50,000 has 
the same fluorescence intensity as an equivalent volume of solution containing 50,000 
FITC molecules. There are no bead standards for eYFP or for other fluorophores such as 
cyan fluorescent protein (eCFP), blue fluorescent protein (eBFP) and red fluorescent 
coral protein (DsRed). Hence, being able to convert measurements performed FITC 




Calculations for FITC to YFP signal conversion. Ignoring any wavelength 
dependence of detector quantum efficiency over emission filter bandwidth, relative 
fluorescence signal F for various fluorophores measured in an instrument at constant 
































    (22) 
where a(λe) is the absorbance for a given fluorophore at the excitation wavelength λe, 
a(λpk) is the maximum absorbance value, ε(λpk) is the molar absorptivity for the given 
fluorophore, fλ is some linear measure of fluorescence intensity at wavelength λ, λd is 
detector wavelength, wd is emission filter band width, Φf is fluorescence quantum yield, I 












λ  is the sum of 
absorbance values from 510-550 nm and ∑
∞
0
λf  is the sum of absorbance values from 250 
nm to 650 nm. Table 1 shows the values for Equation 22 for FITC, Alexa 488, eGFP, and 
eYFP. Dividing the fluorescence of FITC by that of eYFP yields a value for how many 
eYFP yield a signal equal to a single FITC molecule. We calculate a value of 2.0 eYFP 
per apparent FITC. Excel 2003 was used to create a calibration curve of intensity 




Statistics. All values, unless otherwise noted, are means ± SEM where numbers of points 
n are given in the text and/or in the corresponding table. Mean values asserted to differ 




LHR exhibit apparent association on untreated cells and hormone treatments 
affect this apparent association 
 
 Experiments to assess the possible presence of self-association of hLHR on CHO 
cells were performed. Additionally, effects of different hormone treatments on hLHR 
self-association were explored. The technique of homo-FRET was chosen to examine 
self-association of hLHR. This method has the advantage of requiring molecular labeling 
with only a single fluorophore type.  
 
CHO cells were transiently transfected with hLHR-eYFP DNA in 35 mm glass 
bottom petri dish in complete CHO medium containing geneticin and maintained at 5% 
CO2 and 37°C. Transfected cells were incubated at 5% CO2 and 37°C for 20 minutes 
with 100 nM hCG, a ligand that activates the receptor. Transfected cells were incubated 
at 5% CO2 and 37°C for 20 minutes with 100 nM DG-hCG, a related ligand, which 
inhibits receptor activity. Transfected cells not treated were used as the control. Data 
were collected in the dark with the FV300 confocal scanning microscope at room 











Table 1:  Summary of fluorescence parameters for FITC, Alexa 488, eGFP and eYFP excited at 488 nm. These 
quantities can be used to convert flow cytometer signal from FITC bead standards to numbers of other fluorophore 
species that may be present on sample cell surfaces.  
                                                                          















λf  fΦ        Relative fluorescence     
      (au)     (au)         (L mol-1 cm-1)                   (Equation 21) 
FITC   77.3     100 68,000 2981  5010 0.95             28815 
Alexa 488   75.2   100 71,000 3081  4951 0.92             30568 
eGFP   100   100 50,000 2066  3850 0.60             16099 
eYFP   38.1   100 84,000 2723  3809 0.61            13956 
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laser intensity. Fluorescence intensity was collected using a 535/50 nm emission filter. 
Images were acquired in a single plane over time with scan speed set to 0.45 seconds per 
scan. Focus mode was set to x4 to increase scan speed by four fold. Kalman filtering was 
used to average a specific number, typically, 6-8, of raw images for each image recorded. 
A sequence of 20-30 images was recorded per cell. After the sample is placed on the 
microscope stage, a cell is brought into focus on the microscope and viewed in Fluoview. 
Optical zoom ranged from 4x to 7x so that only one cell would be imaged at a time with 
256 by 256 pixels per image. Detector channel voltages, which allow detector 
sensitivities to be adjusted, were set to obtain a suitable bright image. The cell was then 
bleached to ~10% of initial fluorescence intensity. G-factor and background images were 
collected at the end of experiments at every voltage setting used. 
 
 Homo-FRET measurements begin with acquisition of 20 to 30 sequential images 
of fluorescence polarized parallel and perpendicular to excitation polarization as samples 
are bleached. Intensities in parallel and perpendicular images are analyzed to yield 
average intensities and anisotropies in the annular region of interest defined by a mask 
isolating a region of cell membrane. The average intensities and anisotropy upon 
photobleaching are plotted as a function of time (see Figure 24a). Then, intensities are 
normalized to the range 0 to 1 (see Figure 24b), where 1 represents the initial 
fluorescence observed and 0 represents a cell fully bleached. Anisotropy is corrected so 
that the final anisotropy after complete bleach is 0.35. The corrected anisotropy at various 
degrees of photobleaching is then plotted versus normalized fluorescence. Change in 





Figure 24 a-b: Raw data from homo-FRET (a) As the fluorophores are irreversibly 
photobleached over time, anisotropy upon photobleaching increases. This is because, as 
the fluorophore is irreversibly photobleached, density/proximity of the total fluorophores 
decreases. Thus, anisotropy upon photobleaching increases because fluorophores become 
further apart and the value is approaches that of a single fluorophore. (b) Analysis of the 
data is best performed by examination of a plot of anisotropy upon photobleaching vs. 
normalized intensity.    
Frame or time

































































final anisotropy (rfinal or r0), reflects either specific molecular aggregation and/or 
molecular proximity arising simply from concentration. Oligomers of fluorescent species 
have reduced anisotropy relative to that observed with single molecule excited by a 
linearly-polarized laser source because energy transfer from neighboring fluorophores in 
varying orientations. Thus change in anisotropy upon photobleaching can indicate if 
receptors are specifically associated in close proximity due to high receptor densities on 
the surface of the cell. Homo-FRET efficiency (%E) is calculated from rinitial and r0 using 
Equation 21. 
 
Hormone treatment affects apparent hLHR self-association. Anisotropy versus 
normalized intensity for cells undergoing photobleaching was plotted for untreated CHO 
hLHR-eYFP cells and for cells treated with hCG and DG-hCG (Figure 25). Table 2 
shows average anisotropy changes for these three cell groups. For control cells, namely 
those not treated, the average change in anisotropy upon photobleaching is 0.081±0.006. 
After hCG treatment, the change in anisotropy upon photobleaching increases to 
0.099±0.010 for hCG-treated cells, which suggests that that there is increased 
oligomerization caused by this treatment. For DG-hCG treatment, the change in 
anisotropy upon complete photobleaching, decreases relative that for to untreated cells to 
0.058±0.006, which is significantly lower than the control and hCG treated cells. This 
reduced change in anisotropy upon photobleaching for DG-hCG suggests that DG-hCG 
reduces oligomerization relative to untreated cells. Figure 26 shows that the change in 
anisotropy upon photobleaching is larger for hCG compared to the control and DG-hCG, 







Figure 25: The change in anisotropy upon hormone treatment is larger for hCG-treated 
cells compared to the control and DG-hCG treated cells. DG-hCG treated cells exhibited 
the lowest change in anisotropy upon photobleaching. The intrinsic anisotropy was set to 
0.35 which is the value of one fluorophore after all the other fluorophores have been 
irreversibly photobleached. The change in anisotropy upon photobleaching increases with 
hCG treatment, which further supports the notion that hCG increases oligomerization. 
For DG-hCG the change in anisotropy upon photobleaching decreases which is 
significantly lower than the control and hCG treated cells. This decrease in change in 
anisotropy for DG-hCG supports the assertion that DG-hCG suppresses oligomerization. 
 































Table 2: Summary of change in anisotropy upon photobleaching for hCG and DG-hCG 
treated cells plus a control. CHO-hLHR-eYFP cells were untreated and treated with 100 
nM hCG and DG-hCG. Data shown are means ± SEM for indicated number of cells. 
 
Cell Line   Treatments  number of cells     final-initial         
                     examined      anisotropy 
Control    None             67        0.081 ± 0.006 
CHO hLHR-eYFP   hCG (100 nM)          37        0.099 ± 0.010 




























Figure 26: Change in anisotropy upon photobleaching for CHO hLHR-YFP upon hCG 
and DG-hCG treatment. For untreated control cells, the change in anisotropy upon 
photobleaching is 0.081±0.006. The change in anisotropy upon photobleaching increases 
to 0.099±0.010, which further supports that hCG increases oligomerization. For DG-hCG 
the change in anisotropy upon photobleaching decreases to 0.058±0.006, which is 
significantly lower than the control and hCG treated cells. This decrease in change in 




























anisotropy upon photobleaching remained high relative to untreated cells on the plasma 
membrane, supporting that hLHR transiently transfected on CHO cells are constitutively 
oligomerized. This can be seen in more detail in Figure 26 and Table 2. 
 
These anisotropy changes upon photobleaching can be converted to efficiencies of 
homo-FRET between LHR by using equation 16. These average results are shown in 
Figure 27. CHO cells transfected to express hLHR-eYFP at high concentrations exhibit 
relatively high values homo-FRET efficiencies ranging from 17 to 28%. Control cells had 
a homo-FRET efficiency value of 23±2%, FRET efficiencies values exceeding 5% 
generally being considered to be significant [105]. Hence, the extent of apparent FRET 
exhibited by all treatment groups requires explanation. 
  
With 100 nM hCG treatment, homo-FRET efficiency increased from 23±2% to 
28±3% and this small increase in homo-FRET efficiency in cells treated with hCG 
suggests that adding hormone to LHR promotes oligomerization. The homo-FRET 
efficiency decreased from 28±3% to 17±2% when transfected cells were treated with 100 
nM DG-hCG, which inhibits receptor activity. This decrease in homo-FRET efficiency 
suggests that DG-hCG suppresses oligomerization. 
 
In summary, the high FRET efficiencies observed on untreated cells could arise 
either from constitutive aggregation of LHR or possibly from inter-receptor proximity 
caused simply by high receptor surface density. We cannot say which at this point. As 




Figure 27: Homo-FRET efficiencies for CHO hLHR-YFP. Control cells had a homo-
FRET efficiency of 23±2 %. FRET efficiencies of 5% or more are considered significant. 
This suggests that there is aggregation prior to treatment with hCG for transiently 
transfected cells or that the receptor surface is high enough to induce FRET by non-
specific concentrated effects. With 100 nM hCG treatment, homo-FRET efficiency is 
significantly different, compared to the control cells. This small increase in homo-FRET 
efficiency, with cells treated with hCG, suggests that adding hormone to LHR promotes 
oligomerization. The homo-FRET efficiency decreased when transfected cells where 





























fact that we observe increased FRET efficiency after hCG treatment suggests that this 
increase (and only this increase) arises from aggregation. Similarly, for DG-hCG-treated 
cells, since DG-hCG treatment does not decrease surface expression, we infer that the 
decreased FRET efficiency arises from reduced aggregation. However, without further 
information, we cannot identify the origin of the very substantial FRET efficiency still 
present after DG-hCG treatment. Hence, we have not yet demonstrated significant 
constitutive specific receptor aggregation as distinct from possible concentration-based 
FRET caused by high surfaces densities.  
 
LHR expression levels affect apparent receptor self-association 
 
The high extents of FRET between receptors on control cells and on hCG- and 
DG-hCG-treated cells could arise either from specific aggregation of receptors or from 
simple molecular proximity arising from high surface concentrations. If observed FRET 
arises from receptor surface concentrations, then the initial anisotropy of cells should be 
lower for cells with high surface concentrations, that is, for cells with higher fluorescence 
intensities at the start of bleaching. 
 
To determine if receptor density if fact affects anisotropy changes, initial 
anisotropy was examined as a function of normalized initial fluorescence intensity which 
is proportional to receptor surface density for control cells (Figure 28). The uncertainty in 
measurement of g-factors from cell to cell contributes to the variance of among 
anisotropy measurements. To minimize this effect, the g-factor was corrected for each 
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individual cell so that the final anisotropy at complete bleaching was 0.35. As initial 
receptor surface density increased, the initial anisotropy values decreased. For cells 
treated with 100 nM hCG or with 100 nM DG-hCG, as surface density increases, the 
initial anisotropy values also decreased as shown in Figure 29. The slopes of these initial 
anisotropy versus initial intensity plots reflect receptor aggregation as concentration-
dependence of receptor proximity. Table 3 shows slopes of -1.9x10-6±1.2x10-7 and 
-2.2x10-6±1.7x10-7 for the control and 100 nM hCG treated cells, respectively. The 
steeper slope supports the notion that hCG promotes concentration-dependent 
aggregation. Cells treated with 100 nM DG-hCG, a hormone that inhibits receptor 
activity, also demonstrated decreasing initial anisotropy as surface density increased as 
seen in Figure 30. Compared to the control and hCG treatment, the slope of 
-8.8x10-7±2.7x10-7 for DG-hCG is less steep and this supports the idea that DG-hCG 
inhibits aggregation. 
 
Data can also be plotted showing FRET efficiency as a function of initial 
intensity, which is proportional to receptor surface density, for individual cells. These 
data showed that, as receptor surface density increased, so did FRET efficiency (see 
Figure 31). After cell treatment with 100 nM hCG, FRET efficiency increased more 
strongly with surface density, Figure 32. Table 4 shows that the intercepts of these curves 
are grossly equal suggesting high-affinity constitutive aggregation. However, the 
concentration dependence of FRET efficiencies is higher for hCG treated cells. This is 
reflected in the slope values of 5.0x10-4±0 and 5.4x10-4±1.8x10-20 for the control and 







Figure 28: Plot of initial anisotropy versus initial intensity for untreated CHO hLHR-
eYFP cells. As the surface density increases, the initial anisotropy values decrease 
suggesting that low-order oligomers may be predominate at lower receptor concentrations 
while at higher receptor concentrations mostly high-order oligomers. 












































































Figure 29: Plot of initial anisotropy versus initial intensity for CHO hLHR-eYFP cells 
treated with 100 nM hCG. Compared to the control, the hCG treated cells exhibit a 
steeper slope of -2.2x10-6±1.7x10-7 than that for control cells, -1.9x10-6±1.2x10-7, 











































Figure 30: Plot of initial anisotropy versus initial intensity for CHO hLHR-eYFP cells 
treated with 100 nM DG-hCG. Compared to the control the hCG treated cells and the 
slope for DG-hCG slope of -8.8x10-7±2.7x10-7 lower than that for control cells, 












Table 3:  Slope and intercept values for plots initial anisotropy versus initial intensity (proportional to receptor surface density) 
graphs. CHO-hLHR YFP cells were untreated and treated with 100 nM hCG and DG-hCG. Data shown are ± standard 
deviation. 
 
Cell type   Treatment number of                     Intercept      Slope   
     (100 nM)          cells examined                           
 
Control   None         67              4.0x10-1±1.1x10-2        -1.9 x10-6±1.2x10-7     
CHO hLHR-eYFP   hCG        37              4.2x10-1±1.5x10-2        -2.2 x10-6±1.7x10-7   















































Figure 31: Plot of FRET efficiency versus initial intensity for untreated CHO hLHR-
eYFP cells. As the hLHR surface density increased, FRET efficiency increased 















































Figure 32: Plot of FRET efficiency versus initial intensity for CHO hLHR-eYFP cells 
with 100 nM hCG. With 100 nM hCG treatment, there increase in FRET efficiency as 
receptor surface density increased, the intercept of the curve was lower than for untreated 











































Figure 33: Plot of FRET efficiency versus initial intensity for CHO hLHR-eYFP cells 
with 100 nM DG-hCG. With 100 nM hCG treatment, there increase in FRET efficiency 
as receptor surface density increased, the intercept of the curve was higher than for 
















Table 4:  Slope and intercept values for plots of FRET efficiency versus initial intensity, 
which is proportional to receptor surface density, graphs. CHO hLHR-eYFP cells were 
untreated and treated with 100 nM hCG and DG-hCG. Data shown are ± standard 
deviation. 
                                                                            
Cell type          Treatment number of Intercept                  Slope    
          (100 nM)    cells examined          (%)                    
 
Control              None      67                   -13±3          5.0x10-4±3.8x10-5    
CHO hLHR-eYFP      hCG      37                 -17±4                       5.4x10-4±4.3x10-5   






showed increased FRET efficiency as a function of surface density, this indicates that 
hLHR expression levels affect the FRET phenomenon. When cells were treated with 100 
nM DG-hCG, a hormone that inhibits receptor activity, a similar increase in FRET 
efficiency with surface density was observed (see Figure 33). However, compared to the 
control cells and hCG treated cells, the slope of the FRET efficiency versus initial 
intensity plot for DG-hCG-treated cells is less than both, reflecting generally lower 
concentration-dependence of FRET for all DG-hCG cells examined. 
 
 The fact that FRET efficiency on individual cells increases with initial 
fluorescence intensity, proportional to cell’s receptor surface density, could be consistent 
with proximity-induced FRET arising from molecular crowding or with very weak 
specific receptor association. The latter phenomenon would occur if the receptor 
association constant Ka was low so that the extent of association increased as over the 
range of surface concentration explored. However, this sort of concentration-dependent 
specific association for GPCR has not been reported previously. Hence, it seems most 
logical first to consider the concentration dependence of FRET as possibly arising from 
concentration induced molecular proximity. However, the question of whether the actual 
surface concentrations reached in our cells and the fundamental physics of surface 
concentration-induced FRET could explain the observed concentration-dependent FRET 






Transiently transfected cells exhibit a broad range of LHR expression 
 
 The range of receptor expression levels in transiently transfected cells was 
evaluated. Additionally, the number of receptors was in strongly-expressing cells was 
identified. Flow cytometry experiments yielding number of cells having particular 
fluorescence intensities were employed. The cells are hydrodynamically focused into a 
stream consisting of 1xPBS and one cell at a time passes through a 488 nm laser for 
eYFP excitation. An avalanche photodiode detector (APD) is placed along the laser 
excitation beam axis to collect forward scatter, light reflected from the cell in the forward 
direction relative to laser position. Forward scatter indicates cell size because magnitude 
of scatter is proportional to cell size. The second APD is placed 90° to the laser path to 
collect side scatter, light reflected at a larger angle relative to the cell. Side scatter 
indicates cell internal complexity because the light is reflected from the intracellular 
components. Fluorescence emission travels along the same path of side scatter then 
dichroic mirrors direct the light from eYFP to a PMT where fluorescence is collected. 
Fluorescence intensity was collected for Quantum FITC bead standards, three CHO cell 
populations each separately transiently transfected with hLHR-eYFP and an 
untransfected CHO cell population. All cells were maintained at 5% CO2 and 37°C until 
prepared for the cytometer. 
 
 Flow cytometry yields histograms of numbers of cells versus log fluorescence 
intensity. Histograms of control and transfected cells are placed on a comparable basis by 
adjusting the amplitude and x-scale of the control cell histogram until the left half of the 
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control cell and transfected cell peaks optimally align (Figure 34). Then the adjusted 
control cell histogram is subtracted from that of the transfected cells to obtain an 
approximate histogram of successful transfected cells only. This histogram of the 
logarithms of fluorescence intensities can then be converted to linear intensities. A 
calibration curve of intensity measured in the cytometer versus number of FITC per bead 
was obtained using Quantum FITC bead standards. Using the equation for this line, FITC 
numbers per cell were calculated. Finally, using Equation 21, eYFP per FITC was 
calculated.  
 
 Flow cytometry was performed on four cell populations, three transfected with 
hLHR-eYFP and one untransfected population. Figure 35 shows the number of cells 
versus intensity for the three transfected cell populations with the untransfected 
population. Each transfected population has a different range of cells expressing hLHR 
with the second trial YFP 2 having the highest rate of transfection. We focus our 
subsequent attention on this second trial. Figure 34 shows the adjusted control 
untransfected cell histogram and the transfected cell population for the second trial. The 
transfected cell population histogram of the second trial with adjusted untransfected cell 
histogram subtracted is shown in Figure 36. The receptor numbers for the averaged 
transfected cell populations were calculated using a calibration curve (Figure 37) relating 
actual numbers of FITC in calibration beads to apparent numbers of FITC measured 
cytometrically using Quantum FITC bead standards. Numbers of hLHR-eYFP per cell 
were obtained by multiplying the apparent number of FITC per cell by 2.0 (Table 1). 


























Figure 34: Flow cytometry histograms for trial 2 of CHO hLHR-eYFP compared with an 
untransfected population of CHO cells. The histograms were adjusted by optimally 
aligning the left halves of the amplitude and x-scale of both peaks. 































Figure 35: Flow cytometry histograms for three transfected populations YFP 1, YFP 2 
and YFP 3 of CHO hLHR-eYFP. Different receptor expression levels are indicated by 
fluorescent intensity which was digitized in the cytometer on a scale of 0-255 arbitrary 







































Figure 36: Transfected cell population histogram of the second trial with adjusted 
















Figure 37: Calibration curve relating actual numbers of fluorescein isothiocyanate [31] in 
Quantum FITC bead standards to intensity measured in the flow cytometer. 
 Intensity measured in cytometer (Au)


































Figure 38: Average of flow cytometry measurements on transfected cells trials compared 
with an untransfected population. The mode of the difference between transfected and 
control cells occurs at about channel 80, which corresponds to an intensity of about 18, 
about 59,000 FITC, and about 118,000 eYFP. 
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control. A mode was most prominent in transfection 2 (see Figure 36) at approximately 
channel 80. At channel 80, the intensity measured in the cytometer is ~18 which yields a 
FITC signal of ~59,000 and thus eYFP signal of ~118,000. Therefore, the mode was 
118,000 receptors per cell. However, it is obvious that many cells with much higher 
expressions exist in the population. This can also be seen in the averaged data for the 
three transfections (Figure 38). The apparent transfection efficiency is approximately 
25%, approximately 7,400 cells after untransfected cell subtraction, out of a total of 
approximately 24,000 total cells. 
 
Apparent FRET can arise from molecular crowding possibly on transiently 
transfected cells 
 
 FRET occurs when proteins of interest approach each other closely. Here FRET 
can also arise from proximity induced by high concentrations, as well as from specific 
molecular association. Therefore, using homo-FRET hLHR-eYFP numbers measured in 
transiently transfected CHO cells, calculations were performed to determine if a 
substantial amount of apparent FRET/BRET has arisen from molecular crowding. 
Additionally, the possibility that if hLHR-eYFP in lipid rafts affects the apparent 
FRET/BRET phenomenon was considered  
 
 To calculate the probability of FRET that will arise from molecular crowding, 
the probability of no FRET Pno (r) for a molecule in a differential area of 2πr dr around 
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some excited molecule has to be considered, Figure 39. Probability of no FRET is given 
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Since the differential dr is small, Taylor series expansion of ln Pno (r) yields Equation 24, 
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where σ is surface density, r is distance between fluorophores and ro (Förster distance) is 
the distance at which energy transfer efficiency is 50%. The probability of no FRET to 
























P πσ       (25) 
Making the substitution z=(r/r0)
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Figure 39: The probability Pno (r) of no FRET from an excited molecule surrounded by 
possible acceptors in a differential area 2πr dr. 
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where σ is the receptor surface density in receptors per µm2 and r0 is the Förster distance 
in nm. 
 
Using Equation 29, Figure 40 was created for fluorophores with Förster distances 
of 4.5, 6.0, and 7.5 nm. These numbers bracket the range of Förster distance values for 
commonly-used donor acceptor pairs. In Figure 40, as local receptor concentration 
increases so does apparent FRET efficiency. With a 1100 µm2 cell surface area, 5.11 nm 
Förster distance for YFP, and assuming the hLHR is uniformly distributed over the cell 
membrane, the apparent FRET efficiency for a 118,000 total receptors where the mode 
appears in Figure 36 is 1%. For a similar cell with 400,000 receptors, the apparent FRET 
efficiency is 4%. FRET efficiencies of 5%  or greater are often considered significant 
[105] but the possible presence of the receptors in lipid rafts, also has to be considered. If 
these receptors are concentrated into lipid rafts, their local concentration will be higher 
than receptors uniformly distributed over the cell membrane. Previous data have shown 
LHR to be associated with lipid rafts [58, 106]. For the cell membrane area fraction that 








Figure 40: For fluorophores with Förster distances of 4.5, 6.0 and 7.5 nm, apparent FRET 
efficiencies were graphed as a function of local receptor surface concentration. These 
numbers bracket the range of Förster distance values. As local receptor concentration 







































be a typical estimate suggested by other investigators [102, 107]. For a CHO cells with a 
1100 µm-2 surface area where receptors were uniformly distributed and localized in lipid 
rafts covering 10% of the plasma membrane, local receptor concentration would increase 
from 109 µm-2 in the absence of rafts to 1090 µm-2. Therefore, for 118,000 receptors 
apparent FRET efficiency would be 10% and, for 400,000 receptors, 30%. Therefore, if 
most receptors are actually localized in lipid rafts, then most if not all of the FRET levels 
typically observed without hormone could be attributed to molecular crowding. 
 
Since hLHR-eYFP was expressed by transient transfection, the receptors maybe 
experiencing molecular crowding phenomenon from high hLHR expression levels. The 
decreasing trend of initial anisotropy as surface density increases, seen in Figures 28-30, 
may be arising from proximity. As stated earlier, aggregate size lowers anisotropy. If 
there is molecular crowding, anisotropy will decrease due to proximity of nearby 
fluorophores. Therefore, this may further support that there is molecular crowding 
attributed from high expression levels in CHO cells transiently transfected with hLHR. 
 
Homo-FRET reveals constitutive association of MHC class II molecules 
 
A further demonstration that homo-FRET is valuable in evaluating self-
association of other biological systems comes from raw homo-FRET data concerning 
three different types of MHC class II receptors on M12.C3 B lymphoma cells obtained by 
Dr. Jun Zhou and subsequently analyzed by this author. The M12.C3 B lymphoma cells 
contain endogenous MHC class II receptors. The M13C3.F6(αwt/βwt) cells contain fully 
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functional receptors. The M13C3.402(α-12/β-18) cells express the inactive form of MHC 
class II receptors because it is fully truncated. The M13C3.43.28.2(Dα185K/Rβ106E) 
cells express the partially active MHC class II receptors. Homo-FRET data were obtained 
for each cell type with no treatment to determine if MHC class II molecules exist as 
constitutive homodimers. Homo-FRET data were obtained on cells treated with 20 
µg/mL of 10.2.16 mouse anti-Aβ
k monoclonal antibody (mAb), to determine if 
crosslinking the receptor increases oligomerization. Homo-FRET data were also obtained 
in cells treated with 1 mM dibutyryl-cAMP (db-cAMP), which activates cAMP-
dependent protein kinases in the receptor. Finally, homo-FRET data were obtained on 
cells treated with 1% (w/v) methyl-β-cycledextrin (MβCD) which depletes cells of 
cholesterol, a required component of lipid rafts. Decreasing raft formation may decrease 
oligomerization since rafts are known signaling platforms for MHC molecules. 
 
Major Histocompatibility Complex class II molecules were labeled with Alexa 
488 conjugated to hen egg lysozyme (Alexa 488-HEL). HEL is a peptide recognized by 
the MHC class II receptor. The cell lines were cultured for three days with 10 µM of 
Alexa 488-HEL where MHC class II receptors present Alexa 488-HEL on the cell 
surface. The homo-FRET data were collected on the FV300 confocal laser scanning 
microscope using a 488 nm argon ion laser to bleach the cells to ~1% of initial 
fluorescence within approximately 20 images. Dr. Jun Zhou collected homo-FRET data 
and produced plots of average intensity versus image frame and anisotropy upon 
photobleaching versus image frame as cells are irreversibly photobleached graphs. These 
data were subsequently analyzed for this study using Sigma Plot 11.0. Graphs of 
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anisotropy versus fraction of fluorescence intensity were then created and subjected to 
quadratic least squares analysis according to Equation 30 
2
0 bxaxrr ++=        (30) 
where r is anisotropy, r0 is the anisotropy of one fluorophore with no depolarization, i.e. 
when fractional intensity is zero, a is the slope of the plot of anisotropy versus fractional 
fluorescence, x is the fractional fluorescence and b is the graph curvature term. The sum 
of r0+a+b is the initial anisotropy that is when the fractional intensity is one.  Using 
Equation 31, homo-FRET efficiency E% can be calculated. 
100/)(% 0 xrbaE +−=       (31) 
Figure 41a shows confocal images obtained by Dr. Jun Zhou of a M13C3.F6 cell with 
endogenous MHC class II receptors binding HEL peptide conjugated to Alexa 488 with 
no treatment as the peptide is irreversibly photobleached. Figure 41b is the corresponding 
average fluorescence intensity and anisotropy upon photobleaching versus image frame 
number that shows at the peptide is irreversibly photobleached, its anisotropy increases. 
This is because, as photobleaching occurs, the likelihood that two molecules in a dimer 
both remain unbleached decreases and so the ability to exhibit homo-FRET decreases. 
This is because the overall distance between the fluorophores is increasing. Figure 41a-b 
represents confocal images of an M13C3.F6 cell binding HEL peptide conjugated to 
Alexa 488 photobleached over time. Figure 42 shows anisotropy upon photobleaching 
versus fraction of intensity for a single cell with accompanying quadratic least squares 
fitted line. Table 5 summarizes initial anisotropies r0, a values, the slope of the plot of 
anisotropy versus fractional fluorescence, b values, the graph curvature term and FRET 























































Figure 41: (a) Confocal images of untreated M13C3.F6 cell binding HEL peptide 
conjugated to Alexa 488 as the fluorescent peptide is irreversibly photobleached. (b) Plot 
of the cell’s average fluorescence intensity and anisotropy upon photobleaching versus 
image frame number showing anisotropy increase as fluorescence is bleached away. 














Figure 42: Anisotropy upon photobleaching versus fractional intensity for MHC class II 
molecules binding Alexa 488-HEL for a M12C3.F6 cell with quadratic least squares 
fitting. Smooth curve represents Equation 29 fitted to experimental data. 
 

























Table 5: Summary of initial anisotropies r0, a values, the slope of the plot of anisotropy 
versus fractional fluorescence, b values, the graph curvature term and FRET efficiencies 
between peptides bound to I-Ak MHC class II molecules on M12.C3 B. lymphoma cells. 
Data shown are the mean ± standard deviation.  
 
Clone and I-A 
phenotype 
F6(wt/wt) 402(α-18/β-18) 43.28.2(Dα185K/Rβ106E) 
Mean Ag 
presentation 
Normal Inactive Partial/rescuable 









b 0.05±0.14 0.22±0.01 0.06±0.08 
E%   55±9   55±1 77±9 
n1 7 3 7 
MβCD    
r0 







b 0.11±0.09 0.18±0.08 0.16±0.11 
E%   77±5 52±2 59± 14 
n1 5 3 4 









b 0.08±0.06 0.25±0.06 0.34±0.12 
E% 89±4 56±1 72±4 
n1 5 6 4 









b 0.11±0.04 0.17±0.06 0.16±0.15 
E% 50±24   54±6 54± 22 
n1 3 3 3 
 










FRET values of 5% can be considered significant, this is a considerable amount of energy 
transfer showing that MHC class II molecules were oligomerized on M13C3.F6 cells. 
 
When MβCD and 10.2.16 mAb (crosslinker) was used as treatment, FRET 
efficiency increased to 77±5% and 89±4%, respectively. MβCD might be expected to 
theoretically reduce efficiency because it dissipates lipid rafts. However, if MHC class II 
molecules interact strongly with other raft components, then a reduction in the number of 
lipid rafts might yield an increase in the MHC class II concentration in those rafts which 
remain. 10.2.16 mAb treatment should increase FRET because receptors are brought in 
close proximity by crosslinking, as is observed in F6 cells, though not on the other cell 
types.  FRET between MCH class II molecules on cells where db-cAMP was used to 
activate cAMP-dependent protein kinases, compared to the cells not treated, remained the 
same within experimental error at 50±24%. M13C3.402 cells not treated revealed FRET 
efficiency of 55±1% which indicates MHC class II molecules oligomerized on the plasma 
membrane. The FRET efficiencies for MβCD, 10.2.16 mAb, and db-cAMP where all the 
same within experimental error compared to the cells not treated at 52±2%, 56±1% and 
54±6%, respectively. This reveals that non-active MHC class II receptors remain 
aggregated on the plasma membrane. M13C3.43.28.2 cells expressing partially active 
MHC class II receptors had a FRET efficiency of 77±9% for cells not otherwise treated, 
again showing constitutive oligomerization of MHC class II molecules in the plasma 
membrane. Compared to the cells not treated, M13C3.43.28.2 cells treated with MβCD, 
10.2.16 mAb, db-cAMP revealed FRET efficiencies of 59±14%, 72±4% and 54±22%, 
respectively which are within experimental error. Overall, for the three different cell 
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types and treatments, substantial degrees of constitutive dimerization were shown for 




The data demonstrate, first, that hLHRs appear in close proximity in untreated 
living cells since FRET efficiencies of 23% are observed on control cells. hCG treatment 
caused an increase in FRET efficiency compared to the already significant FRET values 
observed for untreated cells. This result supports the notion that hLHR form aggregates 
when liganded [60, 108]. This could also have arisen from hCG activating the receptor, 
causing it to migrate into lipid rafts and form larger oligomers [108]. When treated with 
the antagonist DG-hCG, there was a significant decrease in FRET efficiency compared to 
the control. These data show that antagonist treatment does reduce affect self-association 
of hLHR.  
 
However, expression levels of hLHR have a significant effect on receptor 
association. For hCG and DG-hCG-treated cells and untreated cells, Figures 31-33 show 
that, as receptor as receptor surface density increases, FRET efficiency increases as well. 
Flow cytometry shows that hLHR-eYFP transiently transfected into cells exhibit a broad 
range of expression levels, with most cells having receptor numbers of 118,000 per cell 
but with many much more highly-expressed cells being present. Compared to 
endogenous receptor levels of 20,000 to 40,000 per cell, hLHR-eYFP transfected into 
CHO cells are highly expressed. The high FRET efficiencies, in conjunction with high 
105 
 
hLHR expression levels, suggest that observed apparent FRET arose not only from 
molecular crowding but also from self-association. The FRET efficiency values for cells 
treated with DG-hCG were significant, even though reduced relative to control cells. 
Thus, it is likely that FRET in these cells arises both from specific receptor aggregation 
and from non-specific effects of high receptor surface density. The data clearly show that 
the oligomerization of hLHR is density-dependent. To support this, Figures 28-30 show 
the extent of oligomerization for transiently transfected hLHR as initial anisotropy is 
plotted as a function of receptor surface density. Such behavior has been observed 
previously. For example, Gerritsen and co-workers [109] also found that fluorescence 
anisotropy upon photobleaching of clustered receptors decreases with increasing cluster 
size. Given those observations, study of a cell line more closely resembling naturally 
expressing receptors [61] would lead to a better understanding of the signal transduction 
pathway of LHR. Additionally, lower FRET efficiencies on untreated cells would be 
observed because receptor molecular crowding would be eliminated. 
 
Finally, MHC class II molecules examined by homo-FRET show that this 
technique can be used as a general tool to assess self-association of other biological 
systems. This approach has shown here that active, inactive and partially active MHC 
class II molecules are constitutively dimerized on cells treated with MβCD, a crosslinker 
and db-cAMP, as well as on control cells. These data are summarized in Table 5.  
 
Past experiments by Roess and co-workers suggest that LHR self-associates in the 
plasma membrane after ligand treatment [18, 58, 60, 63-66, 106]. FRAP experiments 
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showed that, for endogenous LHR, lateral diffusion coefficients and recovery percentages 
decreased upon treatment with fluorescently-labeled LH. Moreover hCG bound to LHR 
was laterally immobile on luteal cells, suggesting hCG-binding LHR exist as large 
oligomers [62, 110-112]. Time-resolved phosphorescence anisotropy (TPA), a technique 
that measures rotational correlation times, was used to show that liganded LHR had long 
rotational correlation times, suggesting receptor presence in large aggregates [18, 65]. LH 
and hCG were fluorescently labeled with erythrosin isothiocyanate (ErITC). A non-
functional LHR mutant (LHR K583R) exhibited decreased rotational correlation times 
compared to functional LHR. DG-hCG treatment decreased rotational correlation times 
for both wild type and mutant receptors. TPA measurements on cells treated with 
cytochalasin D, which disrupts actin filaments in cells, showed significantly shorter 
rotational correlation times, indicating that LHR interacts with the cytoskeleton [18]. The 
data shown in this dissertation supports the notion that hLHR forms oligomers with 
hormone treatment. CHO cells transiently transfected to express hLHR-eYFP exhibited 
FRET values ranging from 23% for unliganded receptors to 28% for liganded receptors. 
Additionally, when FRET efficiencies are plotted as a function of receptor surface 
density, slope values become steep from 5.0x10-4±3.8x10-5 for untreated cells to 
5.4x10-4±4.3x10-5 for hCG-treated cells further supporting that hCG promotes 
aggregation of LHR.  
 
Interference fringe FPR, a technique by which diffusion information can be 
gathered from an entire cell, has been applied to the study of LHR diffusion by Roess and 
co-workers [66]. When LHR was liganded with LH or hCG, receptor fractional mobilities 
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were calculated to be 25% lower than the fractional mobility of the non-functional 
receptor, LHR-K583R. This suggested that aggregates of increased molecular size exhibit 
lower lateral diffusion. Hetero-FRET was used to determine self-association of LHR. 
LHR were labeled with mixtures of FITC-LH/tetramethylrhodamine isothiocyanate-LH 
(TRITC-LH) or FITC-hCG/TRITC-hCG. FRET values of ~13% and ~17% for LH and 
hCG treated cells, respectively, were observed. However, a control to test possible FRET 
between unliganded receptors could not be used because there was no suitable 
florescence label for endogenous hLHR. Later, hetero-FRET data for LHR fused to CFP 
and YFP stably co-transfected into cells revealed self-association showing FRET values 
ranging from 0% for unliganded receptors to 18% when liganded [60]. Compared to the 
data shown in this dissertation, transiently transfected hLHR-eYFP showed FRET values 
ranging from 23% for unliganded receptors to 28% for liganded receptors. This further 
supports the notion that transiently transfected hLHR show apparent oligomerization 
which actually arises from molecular crowding. The stably transfected cells for LHR 
fused to CFP and YFP mentioned above show 0% FRET unliganded receptors, 
supporting that a stable cell line expressing physiologically-realistic levels of receptors 
will not show apparent constitutive FRET.  
 
To evaluate possible association of LHR with lipid rafts, Roess and co-workers 
[106] employed isopycnic density gradient ultracentrifugation. For hCG-treated cells, rat 
LHR (rLHR) banded in low density sucrose fractions compared to rLHR not treated with 
hormone. This indicates that rLHR is associated with lipid rafts, since rafts are buoyant 
and appear in low density gradient fractions [113]. Single particle tracking was 
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performed on rLHR-FLAG, in which FLAG is an epitope tag, stably transfected into 
CHO cells. These experiments revealed that rLHR treated with hCG is confined in 
smaller membrane compartments than is untreated rLHR [106]. This, together with 
results of density gradient studies, suggests that rLHR partitions into lipid rafts with 
restricted motion within the raft [106]. DG-hCG treatment, and 1% MβCD significantly 
increased compartment size accessed by rLHR. This would be consistent with LHR 
partitioning into lipid rafts when liganded for receptor aggregation. The data shown in 
this dissertation show that, upon hCG treatment, the changes in anisotropy upon 
photobleaching, were 0.081±0.006 for untreated cells and 0.099±0.010 for hCG-treated 
cells. This supports the notion that hCG promotes self-association; hence it is likely 
hLHR partitions into lipid rafts. Upon DG-hCG treatment, the hLHR anisotropy change 
upon photobleaching of 0.058±0.006 was smaller than that of the untreated cells with a 
value of 0.081±0.006. This shows that DG-hCG treatment suppresses oligomerization 
and may inhibit hLHR partitioning into lipid rafts.  
 
 Roess and co-workers [106] examined three constitutively active hLHR mutants 
by hetero-FRET to investigate possible self-association, as was observed for hLHR-wt 
[58]. For the three mutants and hLHR-wt, CFP- and YFP-fusion proteins were created 
and stably transfected into CHO cells. For all three mutants, liganded receptors showed 
FRET values ranging from 11-15% the same within experimental error as the untreated 
mutants. SPT and isopycnic ultracentrifugation were also performed, though only the 
mutant, LHR-D578H, was examined [58]. SPT showed a much smaller compartment size 
compared to hLHR-wt and the compartment size decreased even more upon hCG 
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treatment. Isopycnic ultracentrifugation revealed there was a moderate shift of hLHR to 
lower sucrose density fractions after hCG treatment. When cells were treated with 
MβCD, there was shift towards the higher density fractions when compared to untreated 
LHR-D578H.  
  
 For all the constitutively active mutants, FRET values were significant for both 
untreated and hCG-treated cells. Since wild-type LHRs are not constitutively active and 
exhibit FRET values of 0% for unliganded receptors and 12% for liganded receptors, the 
FRET observed in this dissertation must arise primarily from molecular crowding on the 
transiently transfected hLHR-eYFP CHO cells examined. The FRET values for hLHR-
eYFP observed in this dissertation are comparable to those of the constitutively active 
hLHR mutants. When the three mutants were treated with hCG, FRET values remained 
the same within experimental error while the hLHR-wt exhibited a significant increase. 
Transiently transfected cells examined in this study showed an increase in FRET values 
upon hCG treatment. This further supports that hCG promotes aggregation of hLHR and 
that aggregates likely partition into lipid rafts upon hormone treatment as Roess and co-
workers observe in their SPT and isopycnic ultracentrifugation studies. In addition, these 
data support the notion that receptor level affects hLHR self-association. The transiently 
transfected hLHR-eYFP that exhibit a broad range of receptor numbers show FRET 
values of 19% for untreated cells and the stable line mentioned above show FRET values 
for 0%. Thus FRET values observed in the present study most likely arise from high 




Segaloff and co-workers [67] reported BRET2 studies suggesting that hLHRs are 
constitutively oligomerized on the plasma membrane. However, this contradicts their 
previously reported co-immunoprecipitation data showing that stably-transfected cells 
exhibit an increase in oligomerization upon treatment with increasing hCG concentrations 
[61]. The co-immunoprecipitation data suggest that hLHR aggregates upon hCG 
treatment. The discrepancy between their previous and current data is likely due to 
transient transfections used to produce LHR-expressing cells for BRET studies. In these 
BRET2 studies, receptor number per cell was not reported. Human embryonic kidney 
(HEK) 293t cells were transiently co-transfected with GFP2-hLHR and Rluc-hLHR. In 
addition, cell lysates instead of live cells were used for the majority of their experiments. 
BRET2 ratios (light emitted by GFP2 divided by that produced by chemoluminescence of 
Rluc) was plotted as a function GFP2:Rluc expression where GFP2 increased in 
concentration as Rluc expression was held consent. These plots for cell lysates were the 
same within experimental error as those for hCG treated cells, suggesting hLHR does not 
aggregate when liganded. BRET2 ratios were also graphed as a function of density of 
sucrose fractions in isopycnic ultracentrifugation to determine possible association of 
LHR with lipid rafts. Again, cells lysed and treated with buffer and hCG gave BRET2 
ratios ranging from 0.2 to 0.3 within experimental error. B50 values, explained earlier in 
background, were calculated for hLHR-wt and hLHR for mutants such as M398T, T577I, 
L457R and D578Y. These results showed that hLHR-wt exhibited B50 values comparable 
to the constitutively-active mutants, suggesting that hLHR-wt is also constitutively 
aggregated. However, there needs to be a comparison of B50 values for hLHR wt and the 
mutants, all after hCG treatment, to confirm these results. Since transient transfections 
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were used and since the number of expressed receptors was not reported, it seems 
possible the apparent constitutive oligomerization of hLHR these authors observed is in 
fact attributable to molecular crowding as shown here in this dissertation. We show that 
cells transiently transfected with hLHR-eYFP exhibit apparent constitutive FRET and 
that hCG promotes self-association. Moreover, the use of cell lysates cannot provide 
unambiguous data if the number of cells lysed per well in the microplate luminometer is 
not reported because more lysates per well can exhibit stronger BRET signals. Since 
receptors per well can vary considerably, this further supports the supposition that the 
BRET2 signal most likely arose from molecular crowding. We show in our data that 
FRET between hLHR is surface density-dependent. When FRET efficiency was plotted 
as a function of receptor surface density for hLHR-eYFP, FRET values increased with 
increasing receptor surface density. Our observations from homo-FRET with transiently 
transfected cells supports Segaloff and co-workers’ co-immunoprecipitation findings 
from their 2004 publication [61] that hLHR may exist as oligomers prior to agonist 
treatment and further increase with hCG treatment, since here in their current publication 
transiently transfected cells using RET are difficult to interpret. In addition, homo-FRET 
only requires one fluorophore. Therefore, the donor/acceptor ratio does not affect FRET 
efficiencies. In contrast, hetero-FRET is dependent on the environment of the donor 
fluorophore because it transfers energy. As we observe in this dissertation, transiently 
transfected cells do not take up DNA at the same ratio for each cell. Thus, achieving a 
donor to acceptor of 1:1 is very difficult. Low donor to acceptor ratios are commonly 
used, so that apparent FRET does not depend on donor concentration. Having more 
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acceptor fluorophores than donor fluorophores allows for one donor fluorophore to 
transfer to multiple acceptor fluorophores [105]. 
 
Clayton and co-workers [23] performed steady-state homo-FRET experiments on 
a stable line of CHO cells expressing serotonin 1A (5-HT1A) receptor. An overall receptor 
concentration of 91/µm2 was reported. They concluded that this receptor was pre-
aggregated and that, upon treatment with agonist, additional oligomerization occurred.  
 
Clayton et al. [23] treated cells transfected with 5-HT1A-eYFP with the serotonin 
agonist, 4-(2´-methoxy)-phenyl-1-[2´-(N-2´´-pyridinyl)-p-iodobenzamido]ethyl-piperzine 
(p-MPPI) the antagonist, MβCD and CD. Untreated cells transfected with 5-HT1A-eYFP 
served as the control. Upon serotonin and p-MPPI treatment, change in anisotropy upon 
photobleaching increased from 0.06 for the control to 0.09 for serotonin and decreased to 
0.05 for p-MPPI antagonist. These results suggested receptor oligomerization upon 
agonist treatment and suppression of receptor aggregation by antagonist. The Authors 
plot anisotropy upon photobleaching versus initial fluorescence intensity, which is 
proportional to surface density, for cells treated with serotonin, p-MPPI, MβCD, 
cytochalasin D (CD) and untreated cells. They observe that anisotropy values for all 
treatments and untreated cells remained constant, showing that 5-HT1A-eYFP aggregation 
of receptors is not affected by the various treatments and treating cells with these reagents 




Clayton et al. [23] also treated cells transfected with 5-HT1A-eYFP with MβCD, 
which depletes cholesterol and destabilizes lipid rafts, and cytochalasin D which 
depolymerizes actin filaments of the cytoskeleton. The change in anisotropy upon 
photobleaching for MβCD was low with a value of 0.03 compared to untreated 5-HT1A-
eYFP which had a value of 0.06. These data suggest that MβCD treatment of 5-HT1A-
eYFP receptors results in decreased oligomerization and function of low-order oligomers 
upon MβCD treatment which may be associated with lipid rafts. With CD treatment, 
change in anisotropy upon photobleaching increased, suggesting that, upon CD treatment, 
5-HT1A-eYFP aggregates into high-order oligomers.  
 
These workers [23] show there is constitutive oligomerization of 5-HT1A-eYFP 
receptors and that the agonist serotonin and the antagonist p-MPPI increase and decrease 
aggregation, respectively. This was observed in our data for hLHR-eYFP transiently 
transfected into CHO cells. When hLHR was treated with hCG, FRET efficiencies and 
change in anisotropy upon photobleaching increased compared to untreated cells and 
upon DG-hCG treatment, FRET efficiencies and change in anisotropy upon 
photobleaching values decreased. These data show that hCG promotes aggregation and 
DG-hCG suppresses it. They show that, with a stably transfected cell line of 5-HT1A-
eYFP expressing 100,000 receptors, that receptor density does not affect anisotropy 
values. Conversely, we observe that as hLHR receptor density increased, FRET 
efficiencies increased as well. Since a stable cell line was used and anisotropy values are 
independent of concentration, it seems that the constitutive self-association of 5-HT1A-
eYFP does not arise from high receptor surface densities. However, we do observe 
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receptor density-dependent anisotropies and therefore the apparent self-association we 
observe could be attributable to molecular crowding.  
 
Finally, Clayton and co-workers [23] also showed a difference in anisotropy 
changes upon photobleaching for MβCD-treated cells as compared with control cells. 
Anisotropy change upon photobleaching significantly decreased upon MβCD treatment, 
5-HT1A-eYFP suggesting the receptor may be in rafts. Therefore, the apparent FRET 
values reported in their study could also arise from proximity of 5-HT1A-eYFP receptors. 
They also report that oligomerization of the receptor is not dependent on receptor 
expression level. They plotted initial anisotropy versus intensity range for 5-HT1A-eYFP 
receptors and showed the intensity remained constant for all treatments and untreated 
cells for 1x10-4 to 4x10-4 AU. It could well be that receptor aggregation is dependent on 
receptor expression level, but that a lower expression level is needed to see this 
dependence. 
 
Hofman and co-workers [114] stably transfected epidermal growth factor receptor 
fused to monomeric GFP (EGFR-mGFP) in NIH 3T3 cells at 50,000 receptors/cell. 
EGFR aids in the growth and development of cells. Using limiting anisotropy values 
determined by time-resolved homo-FRET, they found that there was constitutive 
oligomerization of EGFR-mGFP. Degrees of polarization of 0.93 for mGFP and 0.89 for 
EGFR-mGFP were observed, suggesting that 40% of EGFR-mGFP exist as oligomers 
prior to agonist treatment. For unliganded EGFR-mGFP, degree of polarization was 0.89 
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and, when liganded with epidermal growth factor (EGF) 0.74, indicating further 
oligomerization upon agonist treatment. 
 
These workers [114] also examined EGFR lipid raft association with hetero-
FRET.  Previously they showed, using GM1 labeled with CtxB-Alexa 594 as acceptor 
and EGFR labeled with Alexa 488 as donor, FRET emission increased compared with the 
control indicating that EGFR is associated with lipid rafts [115]. 
 
Hofman and co-workers [114] showed that EGFR-mGFP is constitutively 
aggregated on NIH 3T3 cells. Although these authors’ results are similar to the data 
presented here for cells transfected with hLHR, our data showed that high expression 
levels of hLHR present in transfected CHO cells induce various effects. Such effects 
include FRET efficiency of 23% for unliganded hLHR and 28% for liganded hLHR. We 
thus show that hCG promotes aggregating of hLHR, a result similarly to Hofman et al.’s 
EGFR-mGFP conclusion that EGFR oligomers increase when cells are treated with EGF. 
In contrast to the data presented in this dissertation, they state that there was no 
concentration-dependence of EGFR. They examined a stable cell line, thus the 
observation that EGFR is concentration-dependent is conceivable. We observed an 
increase in FRET efficiency when receptor density increased for hLHR. This may result 
from our use of transiently transfected cells. Such cells exhibit broad receptor range for 
hLHR expression. Since Hofman and co-workers used a stable cell line, it seems possible 
that the constitutively oligomerization they observe does not arise from molecular 
crowding, even with EGFR known to be associated with lipid rafts. However, the extent 
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of possible molecular crowding cannot be determined because EGFR number per cell 
was not reported. Hofman and co-workers’ study of homo-FRET examination of self-
association of EGFR nonetheless shows that homo-FRET is a valuable tool that in the 
study of membrane proteins self-association.  
 
He and co-workers [116] evaluated the homotropic association of Dok 1 
(downstream of tyrosine kinases) and Dok 5 proteins on COS 7 cells. Hetero-FRET 
measurements involving YFP acceptor photobleaching for co-expressed Dok 5-CFP and 
Dok5-YFP showed substantial FRET between these proteins. In addition, Dok1-CFP and 
Dok1-YFP showed significantly increased FRET compared to the control sample, 
namely, cells co-transfected with CFP and YFP not fused to Dok proteins. To determine 
whether certain domains in Dok5 and Dok1 proteins were needed for signaling, the 
pleckstrin homology (PH) domain, phosphotyrosine binding domain (PTB), and the 
carboxyl-terminus (COOH) in Dok 1 and Dok 5 were removed. Dok5-CFP co-expressed 
with Dok5∆PH-YFP revealed no FRET, indicating the PH domain is needed for 
aggregation. In similar experiments involving Dok1, Dok1-CFP co-expressed with 
Dok1∆PH-YFP and Dok1∆PTB-YFP revealed no FRET. These hetero-FRET data 
showed that the PH and PTB domains were both needed for Dok1 aggregation.  
 
In the above study He and co-workers [116] examined transiently transfected 
cells. Low FRET values ranging from 1-4% suggest Dok1 and Dok5 are present at low 
levels. Self-association was observed for Dok1 and Dok5 in addition to association with 
each other. However, protein number per cell was not reported so it cannot be determined 
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whether Dok numbers per cell might affect FRET values or extent of receptor 
aggregation. In our data, we show that FRET between hLHR is density dependent. As 
hLHR receptor density increased, FRET efficiencies increased as well. Since Dok1 and 
Dok5 show low FRET values, it is likely that FRET arises from specific association and 
not from molecular crowding. This drastically differs from our data where we show 
hLHR-eYFP strongly expressed in transiently transfected CHO cells experiences FRET 
simply as a consequence of molecular crowding.  
 
Piston and co-workers [117] used steady-state homo-FRET to evaluate if GFP 
variously attached to MHC class I molecules exhibit different anisotropy values. MHC 
class I molecules are similar to the MHC class II molecules. Both are important in the 
generation of biological immune responses. A construct having GFP attached to the 
cytoplasmic tail of H2Ld MHC class I was termed H2LdGFPin and GFP more rigidly 
attached to the protein via the N-terminal amino acid sequence was termed H2LdGFPout. 
These molecules were transiently transfected into COS 7 cells and fluorescence images 
were collected of COS 7 membrane blebs, bubble-like structures which sometimes 
protrude from cells and which contains no cytoskeleton components. Fluorescence 
polarization as a function of β, the angle from the horizontal when a horizontal excitation 
polarizer is used, was plotted and, MHC class I H2LdGFPin showed uniform 
fluorescence parallel and perpendicular directions, with respect to exciting light 
polarization, at different angles to the plasma membrane which is consistent with random 
orientation of GFP. MHC class I H2LdGFPout showed fluorescence parallel intensities 
that varied significantly at different angles of β while fluorescence perpendicular 
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intensities remained consistent with respect to exciting light polarization. These data 
demonstrated that more rigidly-bound fluorophores would are more suitable for homo-
FRET experiments than more flexibly-bound fluorescent moieties. Homo-FRET 
indicated that, for molecules in the ER, peptide treatment increased FRET for 
H2LdGFPout but not for H2LdGFPin. Change in anisotropy values upon photobleaching 
was measured as percentage changes. The Authors observed changes in anisotropy values 
upon photobleaching for H2LdGFPout of 12% unliganded and 3% for murine 
cytomegalovirus (MCMV)-peptide loaded molecules. For H2LdGFPin, a change in 
anisotropy upon photobleaching was less than 4% for both unliganded and MCMV-
peptide loaded cells. However, they did not analyze the change in anisotropy upon 
photobleaching for blebs, which revealed, for both the H2LdGFPout and H2LdGFPin, that 
mean anisotropies are the same within experimental error. Thus, the two different types 
of fluorophore attachments actually do not affect the FRET observed in plasma 
membrane measurements but obviously had an effect on FRET measured from MHC 
class I molecules in the ER.  
 
In their study Piston et al. [117] may have observed constitutive oligomerization 
of MHC class I molecules in the membrane blebs but this cannot be firmly established, 
since they did not report data of the peptide interacting with the MHC class I molecule on 
blebs. They report mean anisotropy values for MHC class I molecules in the ER of 
0.340±0.002 and 0.343±0.002 for unliganded and liganded H2LdGFPin, respectively. 
Since there is not a significant change in mean anisotropy, there could be constitutive 
FRET between MHC class I molecules in the ER. We observe apparent constitutive 
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oligomerization in our data with homo-FRET efficiencies only differing by 5% from 
untreated to hCG-treated cells transfected with hLHR-eYFP and these data also support 
increased oligomerization upon hormone treatment. Piston and co-workers do see 
increased aggregation of H2LdGFPout in the ER. Unfortunately, they do not report 
receptor numbers or possible raft association of MHC class I molecules. In addition, 
results would have higher physiological relevance if obtained from examination of the 
plasma membrane of intact cells live cells rather than cell blebs. This is because 
membranes on intact have a full complement of intracellular components associated with 
function of surface molecules like MHC class I.  
 
Gerritsen and co-workers [118] used steady-state and time-resolved homo-FRET 
to study FK596-binding protein (FKBP-mGFP) fused to monomeric GFP on NIH 3T3 
cells, a mouse embryonic fibroblast cell line. Homo-FRET data were taken for FKBP-
mGFP and for 2xFKBP-mGFP, a construct containing two FKBP binding domains, with 
and without a ligand AP20187 (AP) known to induce FKBP aggregation. The steady-
state results revealed that AP treatment increased the change in anisotropy upon 
photobleaching and decreased initial anisotropy. A greater change in anisotropy upon AP 
treatment and decrease in initial anisotropy was seen for 2xFKBP-mGFP. An increase in 
change of anisotropy upon agonist treatment along with decreased initial anisotropy 
values indicates receptor oligomerization.   
 
In Gerritsen et al.’s work [118], time-resolved homo-FRET data showed effects of 
ligand binding similar to the steady-state data. However, one-photon excitation (OPE) 
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time-resolved measurements revealed an increased change in anisotropy upon 
photobleaching of approximately 25%. Two-photon excitation (TPE) time-resolved 
homo-FRET yielded similar results, but with a dynamic range 40-50% larger than the 
steady state data.  Initial anisotropy values for time-resolved TPE were lower than OPE.  
 
The studies performed by these workers [118] for both steady-state and time-
resolved who changes in anisotropy upon photobleaching values are relatively small for 
unliganded FKBP-mGFP and 2xFKBP-mGFP compared to liganded receptors, 
suggesting that the protein exists mostly as monomers in untreated cells. Upon AP 
treatment, change in anisotropy upon photobleaching increases showing oligomerization 
for both steady-state and time-resolved homo-FRET. We observe this increase in our 
change in anisotropy upon photobleaching values as well. Change in anisotropy upon 
photobleaching for unliganded hLHR was 0.081±0.006 and, upon hCG treatment 
0.099±0.010. These values are high for unliganded hLHR, suggesting that hLHR-eYFP 
transiently transfected into CHO cells are extensively aggregated before hormone 
treatment. Gerritsen et al. state their transfection preparations are not expected to induce 
cluster formation but do not report the reasons for these expectations or actual protein 
number per observed cell. As mentioned previously, we do observe a decrease in initial 
anisotropy as hLHR surface density increases. Although protein number per cell was not 
reported in Gerritsen et al.’s study, it seems likely that molecular crowding may not be 
present since steady-state initial anisotropy for unliganded FKBP-mGFP receptors were 
close to the anisotropy value of a single mGFP fluorophore. These authors’ use of OPE 
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and TPE in both steady-state and time-resolved homo-FRET shows homo-FRET can be 
accessed in different ways to evaluate self-association of membrane proteins. 
 
Sharma and Mayor [87] report steady-state and time-resolved homo-FRET 
between GFP fused to GPI-anchored proteins when expressed at local receptor 
concentrations of 100-2000/µm2. Transient transfections with GFP GPI-anchored 
proteins on CHO cells were used for these homo-FRET studies. As we observed 
ourselves, their transiently transfected GPI-anchored proteins exhibited a range of cell 
surface densities. They suggest these densities are too low to show significant 
concentration-induced homo-FRET. However, calculations based on the model shown in 
this dissertation disagree. Sharma and Mayor report homo-FRET efficiencies between 
20-40%. For receptors uniformly distributed on the plasma membrane, with a 4.65 nm 
Förster distance and present at 2000/µm2, calculations using Equation 29 suggest the 
apparent FRET of approximately 14% (see Figure 39). Therefore, their FRET values 
seem likely to be attributable to protein concentrations above ~500 µm-2 and they 
observed apparent oligomerization for low local protein concentrations of ~100 µm-2. 
Since Friedrichson and co-workers [119] previously report GPI-anchored proteins are 
associated with lipid rafts, expressed proteins would be concentrated in these raft 
compartments and so that high FRET values could arise from local concentration of GPI-
anchored proteins into lipid rafts occupying only a small fraction of the cell surface. 
 
Scarlata and co-workers [120] used steady-state polarization anisotropy to study 
FITC-conjugated melittin (F-melittin), a tetrameric toxin from bee venom. FITC is fused 
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to an each melittin monomer in the tetramer. Two samples were evaluated, namely a 1:24 
mixture F-melittin to unconjugated melittin and pure F-melittin. Anisotropy upon 
photobleaching was plotted as a function of percent methanol, since methanol induces 
dissociation of tetrameric melittin. Methanol percentages ranged from 0 to 60%. As the 
methanol percentage increased, anisotropy upon photobleaching values decreased for the 
1:24 mixture due to the melittin tetramer dissociating into monomers. Pure F-melittin 
anisotropy upon photobleaching values are significantly lower than those exhibited by the 
1:24 mixture and such anisotropy upon photobleaching values increase with percent 
methanol until 30% methanol is reached. Above 30% methanol, anisotropy upon 
photobleaching values for pure F-melittin approach anisotropy values of the 1:24 
mixture, suggesting the tetramer dissociates at methanol concentrations able 30%. These 
various results demonstrate the self-association of melittin.  
 
The Authors used sodium chloride to induce melittin aggregation. F-melittin and 
1:24 melittin mixture were examined at increasing sodium chloride concentrations 
ranging from 0-1.5 M. The anisotropy upon photobleaching for the 1:24 mixture 
increased from 0.084 to 0.148 with increasing sodium chloride concentration from 0 to 
1.5 M. Since the 1:24 mixture does not exhibit homotransfer, this increase in anisotropy 
upon photobleaching results from ~15% bulk viscosity increase. Pure F-melittin initial 
anisotropy is slightly lower than that of the 1:24 mixture at 0 M NaCl. This is because 
conjugating FITC to melittin removes a positive charge, thus reducing unfavorable 
electrostatic interaction between melittin molecular. The NaCl reduces such repulsions 
between positive charges; therefore a reduction of a positive charge in F-melittin will 
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allow F-melittin to aggregate at lower ionic strength. To demonstrate homo-FRET 
aggregation in a plasma membrane, studies were done using large unilamellar vesicles 
(LUVs) which are made from 1-palmitoyl-oleoyl-sn-glycero-3-phosphorylcholine 
(POPC) lipids. Anisotropy upon photobleaching of POPC LUVs containing melittin was 
plotted versus lipid-melittin ratios for F-melittin, 1:10 and 1:15 F-melittin to melittin 
mixtures. These experiments demonstrated that pure F-melittin remained self-associated 
for POPC:peptide ratios ranging from 2500 to 0. However, both of the mixtures of F-
melittin with unconjugated melittin did not aggregate over a 2000:1 POPC to peptide 
ratios. The 1:15 F-melittin to melittin mixture exhibited the highest anisotropy values 
because it is the least likely to contain fluorescent melittin moieties in close enough 
proximity to transfer energy. These studies show that melittin does self-associate in lipid 
bilayers but studies with live cells would give more information on melittin’s mechanism 
of action; however melittin’s toxicity precludes its use in cellular studies. 
 
In their study, Scarlata et al. showed that the increase in anisotropy upon 
photobleaching for pure F-melittin as increasing methanol concentrations cause 
dissociation shows the size of melittin aggregates. In our work we observe higher initial 
anisotropy values at low receptor densities, as shown in Figures 28-30. This suggests that 
smaller oligomers have elevated anisotropy values since they have fewer LHR neighbors 
to which they can transfer energy. The high anisotropy upon photobleaching values 
exhibited in the 1:15 F-melittin to melittin mixture compared to the 1:10 mixture and 
pure F-melittin show that F-melittin to melittin ratios do affect self-association. We 
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observe this also in our results when FRET efficiency versus hLHR receptor density was 
plotted. As hLHR receptor density increased, FRET efficiency also increased. 
 
Jovin and co-workers [121] used His-tagged venus fluorescence protein (VFP) 
expressed in E. coli cells to study steady-state homo-FRET. They observed that steady-
state anisotropy increased as VFP concentration in E. coli cells decreased, which is also 
observed in the data presented here (Figure 24a). Figure 24a-b represents data for a CHO 
cell transiently transfected with hLHR-eYFP where average initial intensity and 
anisotropy upon photobleaching versus time was plotted. In this graph, as fluorophores 
are irreversibly bleached over time, anisotropy upon photobleaching increases because 
density of fluorophores decreases and, in the limit of complete photobleaching, the last 
individual fluorophore has no possibility of transferring its excitation energy to another 
molecule. Also, time-resolved homo-FRET, as described previously in this dissertation 
was used to image fluorescence anisotropy of epidermal growth factor (erbB1) receptor 
fused to eGFP and stably expressed in  CHO and A431 cells [122]. A plot of anisotropy 
as a function of fractional fluorescence intensity remaining as photobleaching proceeds 
was created, showing that anisotropy increased as fractional intensity decreased for 
erbB1-eGFP on CHO cells. This supports the trend demonstrated for Figure 24b, where 
anisotropy upon photobleaching was plotted versus fractional intensity. In this graph, 
anisotropy upon photobleaching increases as fractional intensity decreases. A431 cells 
have endogenous erbB1 receptors as well erbB1-eGFP introduced by transfection. The 
combination of erbB1-eGFP and non-fluorescent erbB1 will result in low energy transfer 
because erbB1-eGFP may not be in proximity to another erbB1-eGFP. When time-
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resolved anisotropy versus fractional fluorescence intensity was plotted for A431 cells, 
anisotropy upon photobleaching remained constant. Their data, in conjunction with the 
data presented in this dissertation, demonstrate that homo-FRET can be used to evaluate 
receptor interactions. When anisotropy is plotted as a function of fractional intensity, 
anisotropy increases and receptor interaction are being observed. 
 
Conclusion and future directions 
 
In summary, this study demonstrates that CHO cells transiently transfected with 
hLHR-eYFP exhibit spontaneous FRET on untreated cells, as well as on cells exposed to 
hCG and DG-hCG treatments. Substantial FRET efficiencies were observed for hCG and 
DG-hCG treated cells as well for untreated cells. Hormone treatment affects hLHR 
association. Upon hCG treatment, FRET efficiencies and change in anisotropy upon 
photobleaching increased compared to untreated cells, showing that hCG promotes 
oligomerization. For DG-hCG treated cells, FRET efficiencies and change in anisotropy 
upon photobleaching decreased, showing DG-hCG suppresses oligomerization. Secondly, 
hLHR expression levels affect self-association. FRET efficiencies increased as hLHR 
surface density increased for hCG and DG-hCG treated cells as well as for untreated cells 
suggesting substantial FRET arises simply from receptor proximity. Also, a decrease in 
anisotropy upon photobleaching values as hLHR surface density increased further 




CHO cells transiently transfected with hLHR-eYFP have a broad distribution of 
receptor numbers per cell. In this distribution a substantial fraction of cells exhibit high 
receptor numbers compared to levels in cells naturally expressing LHR. We estimate that 
our measurements were typically performed on cells expressing ~118,000 receptors or 
more per cell. A substantial amount of apparent FRET may arise from molecular 
crowding, especially if the receptors are concentrated by location in lipid rafts, as has 
been demonstrated previously for hLHR. It seems possible that, in studies of transiently 
transfected cells, much of the observed FRET/BRET may arise from high densities of 
receptors on the surface, i.e. molecular crowding. Hence receptor number per cell should 
always be reported so that possible effects of molecular crowding can be assessed. 
However, this observation does not rule out the possibility that hLHR may also form 
dimers or low-order oligomers in the ER which are then trafficked to the plasma 
membrane. Either LHR monomers or such oligomers upon hCG treatment may then 
undergo further oligomerization as demonstrated by our data. Therefore, our results agree 
with previous data from Segaloff et al. [61] and Roess et al. [106] that hLHR aggregates 
to some extent  upon hCG treatment. 
 
Finally, homo-FRET can be used as a general tool to evaluate self-association of 
other biological systems, such as was shown here using MHC class II molecules. For 
normal, inactive and partially active MHC class II molecules, constitutive dimerization 
was observed for control cells and for cells subjected to MβCD, crosslinking and 




This study shows that, to accurately assess possible receptor aggregation in 
plasma membranes using biophysical techniques such as FRET and BRET, it is important 
to take specific factors into consideration. The first factor is protein number per cell, 
more particularly, the number of receptors per unit area of the cell surface. High protein 
surface concentrations can give rise to apparent FRET and BRET by reason of simple 
proximity, i.e. molecular crowding. This can be misinterpreted as arising from specific 
association. In particular, transiently transfected cells exhibit a wide range of receptor 
expression levels, and FRET and BRET measurements tend to focus on the most 
fluorescent, i.e. most highly expressing, cells in the population. It is important to 
measure, at least approximately, receptor number in cells studied for comparison with 
number of receptors occurring naturally receptors on cells of physiological interest. A 
second factor is lipid raft association. If proteins are in lipid rafts, local protein 
concentrations can be significantly increased. Thus molecular crowding may give rise to 
even higher extents of apparent association which are not relevant to receptors occurring 
naturally on cells.  
 
Future experimentation should involve treating CHO cells expressing hLHR-
eYFP with MβCD to disrupt lipid rafts by cholesterol depletion. This would reduce local 
receptor concentration, thereby lowering FRET if lipid rafts can contribute to effects 
induced by molecular crowding. Additionally, another useful experiment will be to 
examine Cyanine 5 (Cy5) labeled hLHR on cells expressing CFP-Epac-YFP probe, 
where Epac is an abbreviation for Exchange Protein directly Activated by CAMP. This 
experiment allows evaluation of the possibility of continuous cell activation and cAMP 
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signaling, simply as a consequence of high receptor densities. When cAMP is not bound 
to Epac, CFP and YFP are in proximity and CFP excitation causes energy transfer and 
fluorescence emission from YFP. After Epac binds cAMP, the Epac probe unfolds so that 
CFP and YFP are not in proximity and only CFP fluorescence emission will be observed. 
This experiment would be executed using flow cytometry to monitor CFP and YFP 
fluorescence intensities to assess cell activation while Cy5-hLHR intensities is monitored 
simultaneously to assess receptor surface density.  
 
 It is still unclear the extent to which LHRs expressed at endogenous levels maybe 
constitutively aggregated and how much ligand binding may cause them to further 
aggregate. Therefore, another useful experiment would be to obtain a stable cell line 
exhibiting physiologically-relevant receptor levels of 20,000 to 40,000 receptors per cell. 
These cells could be examined using homo-FRET before and after hCG and DG-hCG 
binding. In addition, fluorescent GM1, a marker for lipid rafts, could be used in hetero-
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LIST OF ABBREVIATIONS 
 
5-HT1A: Serotonin 1A receptor 
AC:  adenyl cyclase 
AP:  AP20187 ligand 
APD:  Avalanche photodiode 
ARF6:  ADP-ribosylation factor, isotype 6 
ARNO: ADP-ribosylation factor nucleotide-binding site opener 
Asn:  asparagine 
ATP:  adenosine triphosphate 
ADP:  adenosine diphosphate 
Au:  arbitrary units 
B:  BRET signal 
B50:  half max BRET signal 
BRET:  bioluminescence resonance energy transfer 
BSA:  bovine serum albumin 
cAMP:  cyclic adenosine monophosphate  
CD:   cytochalasin D 
CFP:  cyan fluorescent protein 
CHO:  chinese hamster ovary 
CL:  corpus luteum 
COOH: carboxylic terminal 
CtxB:  cholera toxin subunit B 
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Cy5:  indodicarbo-cyanine 
Cys:  cysteine 
D:  diffusion coefficient 
Da:  dalton 
Dansyl: 1-dimethylanimonaphthalene-5-sulfonyl chloride 
Db-cAMP: dibutyl-cyclic adenosine monophosphate 
DG-hCG: deglycosylated-human chorionic gonadotropin 
DiI:  1,1'-Diotadecyl-3,3,'3' – tetramethylindocarbocyanine iodide 
DMEM: dulbecco’s modified minimum essential medium 
Dok:  downstream of tyrosine kinases 
DRM:  detergent-resistant membrane 
DsRed: ref fluorophore coral protein 
E. coli:  Escherichia coli 
E:  percent energy transfer efficiency 
eBFP:  enhanced blue fluorescent protein 
eCFP:  enhanced cyan fluorescent protein 
EDTA: ethylenediaminetetraacetic acid 
EGF:   epidermal growth factor 
eGFP:  enhanced green fluorescent protein 
EGFR:  epidermal growth factor receptor 
Eh:   homo-FRET percent energy transfer 
emFRET: energy migration fluorescence resonance energy transfer 
Epac:   exchange protein activated by cAMP 
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ER:  endoplasmic reticulum 
erbB1:  an epidermal growth factor receptor 
eYFP:  enhanced yellow fluorescent protein 
F:  fluorescence signal 
FBS:  fetal bovine serum 
FCS:  fluorescence correlation spectroscopy 
FCεRI: Type I FCε receptor 
FITC:  fluorescein isothiocyanate 
FKBP:  FK596-binding protein 
FLAG:  epitope tag 
FLIM:  fluorescence lifetime imaging microscopy 
F-melittin: fluorescein isothiocyanate conjugated to melittin 
FMPP:  familial male-limited precocious puberty 
FPR:   fluorescence photobleaching recovery 
FRAP:  fluorescence recovery after photobleaching 
FRET:  Förster resonance energy transfer 
F-SConA: fluorescein- succinyl concanavalin A 
G(τ):  time autocorrelation function of a signal 
G:  g-factor 
GDP:  guanosine diphosphate 
GFP:  green fluorescent protein 
Gly:  glycine 
GM1:  membrane ganglioside 
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GPCR:  G protein-coupled receptor 
GPI:  glycosylphosphatidylinositol 
Gs:   stimulatory G protein 
GTP:  guanosine triphosphate 
hCG:   human chorionic gonadotropin 
HEK:  human embryonic kidney 
HEL:  hen egg lysozyme 
hetero-FRET: heterotransfer fluorescence resonance energy transfer 
hLHR:  human luteinizing hormone receptor 
homo-FRET: homotransfer fluorescence resonance energy transfer 
IgG:  immunoglobulin 
Ii:  invariant chain 
J:  spectral overlap 
LH:  luteinizing hormone 
LHR:  luteinizing hormone receptor 
LUV:  large unilamellar vesicle 
M:  mean square displacement 
mAb:  monoclonal antibody 
MCMV: murine cytomegalovirus 
MESF:  molecules of equivalent soluble fluorophores 
mGFP:  monomeric green fluorescent protein 
MHC:  Major Histocompatibility Complex  
MIIC:  MHC class II containing compartments 
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MSD:  mean square displacement 
MβCD: methyl-beta cyclodextrin 
OPE:  one photon excitation 
PALM: photoactivated localization microscopy 
PBS:  phosphate buffered saline 
PFRET:  probability of Förster resonance energy transfer  
PH:  pleckstrin homology 
p-MPPI: 4-(2´-methoxy)-phenyl-1-[2´-(N-2´´-pyridinyl)-p-iodobenzamido]ethyl- 
  piperzine 
 
PMT:  photomultiplier tube 
Pno (r):  probability of no Förster resonance energy transfer 
POPC:  1-palmitoyl-oleyol-sn-glycero-3-phosphorylcholine 
PTB:  phosphotyrosine binding domain 
r:  anisotropy 
r0:  Förster distance 
RET:  resonance energy transfer 
rLHR:  rat luteinizing hormone receptor 
RNA:  ribonucleic acid 
S ConA:  succinyl concanavalin A 
Ser:  serine  
Ser:  serine 
SPT:  single particle tracking 
STED:  stimulated emission depletion microscopy 
STORM: stochastic optical reconstruction microscopy 
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Thr:  threonine 
TM:  transmembrane 
TMR:  tetramethyl rhodamine 
TPA:  time-resolved phosphorescence anisotropy 
TPE:  tow photon excitation 
TRITC:  tetramethylrhodamine isothiocyanate 
Tyr:  tyrosine 
VFP:  visible fluorescent protein or venus fluorescent protein 
Wt:  wild type 
YFP:   yellow fluorescent protein 
β2-AR: beta 2 adrenergic receptor 













This section includes other work I have done at Colorado State University while 
working towards my degree of Doctor of Philosophy. 
 
In fall, 2006, I was diagnosed with an uncommon phyllodes tumor in my left 
breast and on March 19th 2007 underwent a simple mastectomy with breast 
reconstruction. This appendix a case report of my surgery with a brief review of 
phyllodes tumors, which I wrote and recently published. I was the originating author of 
initial and revised manuscript versions and corresponding author for the publication. 
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IMMEDIATE BREAST RECONSTRUCTION WITH SALINE IMPLANT AND 




Phyllodes tumors are uncommon tumors of the breast that exhibit aggressive 
growth. While surgical management of the tumor has been reported, a single surgical 
approach with immediate breast reconstruction using AlloDerm has not been reported. 
 
Case presentation 
A 22-year-old woman presented with a 4 cm mass in the left breast upon initial 
examination. Although the initial needle biopsy report indicated a fibroadenoma, the final 
pathologic report revealed a 6.5 cm x 6.4 cm x 6.4 cm benign phyllodes tumor ex vivo. 
Treatment was a simple nipple-sparing mastectomy coupled with immediate breast 
reconstruction.  After the mastectomy, a subpectoral pocket was created for a saline 
implant and AlloDerm was stitched to the pectoralis and serratus muscle in the lower-
pole of the breast. 
 
Conclusions 
Saline implant with AlloDerm can be used for immediate breast reconstruction 






Cystosarcoma phyllodes was first described in 1838 by Johannes Müller but was  
not found to be malignant until 1943 by Cooper and Ackerman [1]. It is now commonly 
called phyllodes tumor.  It is less than 1% of breast tumors and exhibits unpredictable 
behaviour.   
 
Reports in literature have been focused on surgical approaches to the tumor 
removal. Although patient assessment prior to tumor removal often includes plans for 
immediate breast reconstruction, these approaches are rarely reported unless the tumor is 
classified as giant or is in an adolescent female [2-5]. Usual tumor treatment is wide local 
excision and simple mastectomy [6-8]. However, there have been few reports on breast 
reconstruction with phyllodes tumors, especially within the last 10 years.  Because of the 
fast growth rate of these tumors, a greater than a 1 cm negative margin is preferred with 
tumor removal and a mastectomy may have to be performed to prevent local 
reoccurrence. Breast reconstruction usually consists of a transverse rectus abdominis 
musculocutaneous (TRAM) flap or a latissimus dorsi (LD) musculocutaneous flap as in 
other breast cancers.  
 
Here we report a single surgery that includes reconstruction of the breast 
immediately post-mastectomy using a saline implant and AlloDerm. AlloDerm is 
becoming increasingly popular for immediate breast reconstruction. It is a viable option 
for athletic or thin women for whom TRAM or LD is not possible. A submuscular pocket 
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can be created for a breast implant and AlloDerm is used to give lower-pole fullness. It 
helps fill the breast flap when subcutaneous tissue is limited and supports the breast 




The patient was a 22-year-old African American female who presented with a left 
breast mass. The mass had been present for at least 3 months. The left breast was larger 
and leaked a clear fluid. Upon initial examination, the patient’s primary care provider 
observed a 4 cm mass. The patient also experienced pain down the left arm which was 
reported about a week after the initial exam.  Her aunt on her father’s side had been 
treated for breast cancer at 39. She had no past medical or surgical history, did not use 
tobacco, and menarche occurred at 11 years of age.  
 
Ultrasound of the left breast (Figure 43) revealed a 9 cm x 9 cm x 4.5 cm 
hypoechoic mass centered at the 12-1 o’clock area. The anterior of the mass appeared to 
be within 1 cm of the skin and the posterior was on the pectoral muscle.  The echotexture 
varied from hypoechoic to isoechoic and there are small cystic areas within the mass. 
There were no other masses identified in the left breast or the left axilla. The mass was 
deemed suspicious for malignancy and the assessment was Bi-RADS 4b. The patient was 




Figure 43: Ultrasound of benign phyllodes tumor in left breast. 
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Upon surgical consultation a core needle biopsy was performed with a 22-gauge 
needle; four biopsies were obtained. The biopsies were consistent with a fibroadenoma, 
 indicating a benign tumor, which was consistent with the presentation of most 
cystosarcomas in core needle biopsies [11, 12].  
  
The patient underwent a simple mastectomy with immediate breast 
reconstruction. Because the tumor volume was approximately two thirds of the breast and 
lumpectomy would result in poor cosmetic outcome, simple mastectomy with nipple-
areola complex (NAC) preservation was performed on the patient. Standard breast 
reconstruction usually consists of a transverse rectus abdominis musculocutaneous flap or 
a latissimus dorsi musculocutaneous flap. However, the patient did not have adequate 
fatty tissue at the abdomen for the TRAM procedure and the patient did not want the 
large scar across the abdomen that would result. The plastic surgeon thought LD was the 
better choice because it would provide a “living” breast but this still required a small 
implant. The patient opted for a saline implant with AlloDerm to the mastectomy site and 
a mastopexy (breast lift) or mastopexy and implant to the other breast for symmetry. 
Because breast reconstruction was coupled with mastectomy using AlloDerm, there was 
no need for a TRAM or LD surgery which reduced scarring and the patient’s overall 
recovery time. 
 
The simple mastectomy consisted of an incision along the mammary crease. 
Dissection of the breast was carried out by cutting down the anterior pectoral fascia and 
dissecting to approximately 1 cm from the clavicle. Medial dissection was carried out to 
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the left lateral border of the sternum and lateral dissection was carried over to the anterior 
border of the latissimus dorsi muscle. A bovie electrocautery was used to create a 
superior flap of the entire left breast.  
 
Next, breast reconstruction was performed. At the level of the inframammary 
fold, the pectoralis muscle was divided from 4 to 8 o’clock and a subpectoral/subserratus 
pocket was made using an electrocautery. At the mastectomy site, the superior pole of the 
breast flap was thicker than the inferior pole. Therefore, the superior breast tissue was 
laterally divided and sutured under the skin and to the pectoralis muscle with 3-0 
Monocryl. This smoothed out the contour of the superior pole. AlloDerm, used to give 
more lateral fill, was sutured to the inframammary fold and to the part of the pectoralis 
muscle with 3-0 polydioxanone. The saline implant was then inserted into the pocket.   
The flap was advanced down, sutured into place, and the implant was filled. A drain was 
inserted and the incision was closed with Monocryl and Dermabond. For symmetry, the 
other breast underwent vertical mastopexy and positioned by making the superior border 
of the areola at the same level as the other breast. 
 
Grossly, the excised encapsulated mass measured 6.5 cm x 6.4 cm x 6.4 cm. The 
surface was tan with a whorled appearance. Pathologic findings were consistent with a 
benign phyllodes tumor displaying large leaf-like projections surrounded by uniform 



























There were no postoperative complications and hospital stay was 24 hrs.  The 
patient is currently 41 months post-surgery and has not had local reoccurrence.  The 
patient is very pleased with the cosmetic outcome (Figure 46) and feels that immediate 




Phyllodes tumor is a disease of the epithelial and stroma tissue in the breast. It is 
classified as benign, borderline, and malignant. Malignant tumors have high stroma 
cellularity and tend to be permeative whereas benign tumors have low stroma cellularity 
and are circumscribed [6, 7, 13, 14]. Borderline tumors cannot be distinguished between 
the two because of the uncertainty of their behavior. These tumors can be encapsulated 
and their size typically ranges from 1-45 cm [6]. These tumors, when discovered, are 
usually large from their aggressive growth rate and at beginning stages, cause virtually no 
pain or other symptoms [15]. Larger tumors can result in nipple discharge, deformity of 
the skin, pain from the tumor weight, or pain from the impact on nerves [8, 15]. There is 
no correlation between size and tumor malignancy [7, 16].  
 
Treatment for the disease usually involves wide local excision with negative 
margins greater than 1 cm [6-8]. If there is poor tumor to breast size, simple mastectomy 
is recommended. There have been a few cases reported of benign tumors metastizing but 
this is very rare [7]. These tumors tend not to metastasize to the axillary lymph nodes but 







Figure 46: (a) Preoperative view of phyllodes tumor in left breast. (b) Postoperative view 
after 4 years with nipple-sparing mastectomy.* 
 









generally are not used because the benefit of these therapies is unclear [6, 7, 17]. 
However, if the margins are less than 1 cm and there is chest wall invasion, adjuvant 
radiotherapy should be strongly considered [6].  
 
As discussed in this report, breast reconstruction can be performed immediately 
after tumor removal. Although immediate breast reconstruction is oncologically safe to 
perform after mastectomy [9], Mortenson and co-workers found wound healing 
complications increased from 8.3% to 22.2% [18]. In three breast reconstruction groups, 
the tissue expander/implant, TRAM, and LD group, the site complications were 11.5%, 
33%, and 83% within their own group, respectively.  
 
In breast reconstruction, the NAC is preserved, if possible, for the best cosmetic 
outcome. It is still controversial to preserve the NAC when the tumor is cancerous and 
centrally located because it is unclear if the NAC is involved with breast cancer [19] .If 
removed, the NAC can be reconstructed. Common techniques to reconstruct the NAC are 
skin graft and tattoo but it is difficult to obtain nipple symmetry and reconstructed nipples 
often have poor nipple projection, color match, shape, and texture [19].  
 
There are four main incisions for nipple-sparing mastectomy. The superior or 
inferior periareolar with lateral extension, transareolar with perinipple and lateral-medial 
extension, transareolar and transnipple incision with medial and lateral extension, and 
mammary crease that is inferior or lateral. The superior or inferior periareolar with lateral 
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extension allows good exposure for tumor removal but may compromise blood supply to 
the periphery of the flap and areola [19, 20]. The transareolar with perinipple and lateral-
medial extension also provides good exposure and reduces the risk of ischemia to the 
lower portion of the areola. However, care must be taken not to divide the perinipple 
artery from the breast parenchyma causing perinipple scaring resulting in downward 
nipple projection [19, 20]. The transareolar and transnipple incision with medial and 
lateral extension provides good exposure to the lactiferous ducts for dissection and good 
vascularity to the areola and nipple, but the apical portion of the nipple may still suffer 
from ischemia or necrosis [20]. The mammary crease approach, inferior, was used here. 
The scar is the least visible and the skin flap vascularization is supported by superior and 
medial vessels [19, 20]. Vascularization of the nipple and areolar are not disturbed with 
this incision [20]. This incision is best for smaller breast with low ptosis as it may be 
difficult to reach parasternal and subclavicular areas of the breast for tumor removal. All 
incisions have equal risk of necrosis but women under 45 years of age had a higher rate 
of NAC viability [21].  
 
Since immediate breast reconstruction is being used with increasing frequency, 
more surgical approaches are needed for fast recovery. AlloDerm is an acelluar dermal 
matrix from human cadaver skin. The skin has no cellular components and, for this 
reason, rejection is not an issue [9]. The use of AlloDerm in breast reconstruction has 
many advantages. It can be used off the shelf  which reduces operation time [9]. If there 
is not enough subcutaneous tissue to fill a skin flap, AlloDerm can be used to fill out the 
inferior pole of the breast. AlloDerm also helps visually to reduce rippling, stark 
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contours, and bottoming out seen with larger implants [9, 10]. It also shortens recovery 
time. Hospital stay for AlloDerm/implant breast reconstruction was found to be an 
average of 48 hours [22]. It is safe to use and provides another option for immediate 




Management of phyllodes tumors has many challenges which need to be 
addressed on a case by case basis. In this case, a simple mastectomy was the best option 
for a young patient with a comparatively large tumor mass. Although LD with an implant 
was thought to be the best choice for breast reconstruction, the patient opted for just a 
saline implant with AlloDerm and mastopexy for symmetry. The cosmetic outcome was 
good. Therefore implant reconstruction with AlloDerm should also be considered along 
with LD and TRAM if the patient wants minimal scarring and reduced recovery time.  
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